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1 
INTRODUCTION 
               Midline laparotomy surgery is done commonly in our institution. 
Pain associated with   laparotomy causes undue distress and is injurious to the 
patient. In addition to the pain being physically and emotionally 
incapacitating, it is accompanied with several physiological effects which 
augment the perioperative stress response.  
The postoperative pain prevents early ambulation of the patient, thus 
making them prone to deep vein thrombosis, pulmonary atelectasis, muscle 
wasting and urinary retention that ultimately contributes to increased 
morbidity,   increased length of hospital stay and at times even mortality. 
Adequate postoperative analgesia is essential to prevent complications such as 
systemic hypertension, myocardial ischemia or infarction, cardiac 
arrhythmias, respiratory compromise, pneumonia, postoperative ileus and 
delayed wound healing.1 Moreover, the severity of acute pain may lead on to 
distressing postsurgical chronic pain.2 Pain after laparotomy is more 
pronounced in the first 48 hours postoperatively and is aggravated during 
mobilisation or coughing, than during rest. 
Epidural analgesia is a recognised technique which is considered as the 
gold standard in the management of postoperative pain. Epidural analgesia is 
commonly used in perioperative and postoperative period. It has been 
demonstrated to improve postoperative outcome and attenuate the 
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physiological stress response in the postsurgical period. But the technique of 
epidural analgesia is not without complications which may include postdural 
puncture headache, total spinal anaesthesia, seizures due to unintentional 
vascular injections, epidural hematoma and epidural abscess. Moreover, 
physiological side effects such as hypotension, motor blockade, and urinary 
retention are not uncommon.3  
       The use of multimodal analgesia techniques to facilitate the patient 
with adequate analgesia for laparotomy surgeries involving midline incisions 
extending anywhere between xiphisternum and pubic symphysis had been 
used, to reduce the perioperative use of opioids and its ill effects. With the 
advent of Ultrasound guidance, the anaesthesiologists now are reconsidering 
old techniques for extensive clinical use. The rectus sheath block (RSB) is an 
old but useful technique, under-utilized in the adult population. 
          The rectus sheath block is an old regional anaesthetic technique but 
with the advent of long acting local anaesthetic agents and compact portable 
ultrasound equipment, it has re-emerged as a novel analgesic technique for the 
management of postoperative pain.4 The technique aims to block the ventral 
rami of T7-T12 intercostal nerves that innervate the rectus abdominis muscles 
and overlying skin.5 It is a compartmental block done by injecting local 
anaesthetic into the potential space between the rectus muscle and the 
posterior rectus sheath. By introducing a catheter in situ within this space, the 
3 
block can be topped up using intermittent bolus at regular intervals or 
continuous infusion of local anaesthetics.  
Taking all these into consideration we decided to conduct a prospective 
randomized controlled study at Govt. Stanley Medical college hospital, 
comparing the analgesic efficacy of USG guided rectus sheath block (RSB) 
with thoracic epidural analgesia (TEA) for postoperative pain relief in patients 
undergoing midline laparotomy surgery under general anaesthesia. 
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AIM OF THE STUDY 
To compare the analgesic efficacy of USG guided Rectus Sheath Block 
with Thoracic Epidural Analgesia for postoperative pain management 
following midline laparotomy surgery. 
 
OUTCOMES MEASURED 
Primary Outcome measures: 
 Assessment of the postoperative pain by Visual Analogue pain score 
(VAS). 
Secondary Outcome measures: 
a. Postoperative Nausea and vomiting (PONV) 
b. Rescue Analgesic requirement 
c. Patient Satisfaction 
d. Therapeutic/Technical failure rate. 
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ANATOMY OF EPIDURAL SPACE   
          Vertebral column is made of  7 cervical, 12 thoracic, 5 lumbar, 5 sacral 
and 4 coccygeal vertebrae. The spinal canal is formed by the adjacent 
vertebral formina. The spinal canal offers support and protection to the spinal 
cord and its nerve roots.6 
         The spinal cord and its root are surrounded by three layers of membrane, 
inner most is the piamater. The second layer is the arachnoid mater and the 
space between the piamater and arachnoid mater is the subarachnoid space 
filled with cerebrospinal fluid. The outermost layer is the duramater and the 
space between the arachnoid and  the duramater  is the subdural space and 
finally the space out side the dura mater is the extradural (or) epidural space. 
 
Figure 1: Anatomy of vertebral column 
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   To enter the epidural space the needle has to pass through skin, 
subcutaneous tissue, supra spinous ligament, inter spinous ligament and 
ligamentum flavum.  
EPIDURAL SPACE  
It is a potential space which extends from the foramen magnum to the 
sacral hiatus and surrounds the duramater anteriorly, laterally and posteriorly 
(Fig.2).  
 
Figure 2: Anatomy of epidural space 
 
 
 
7 
It has the following boundaries  
 above: foramen magnum 
 below: sacrococcygeal ligament  
 anterior: posterior longitudinal ligament 
 posterior: lamina, ligamentum flavum 
 lateral: pedicle, intervertebral foramina 
CONTENTS OF THE EPIDURAL SPACE:  
Fat, areolar tissue, lymphatics, veins and nerve roots are present in the 
epidural space, without any free fluid. The volume is more in obese people 
and less in elderly people, due to reduction in the epidural fat there by leading 
to reduction in dose requirements.  
Also in obese patients and pregnant females there is an increased 
chance of catheter migration due to compression of Inferior vena cava and 
also due to continuation of Bateson’s plexus of veins with iliac veins in the 
pelvis and azygos veins of thorax  and  abdomen.  Usually, the distance of the 
epidural space from the skin is about 4.5-5cm in 75-80% of individuals and 
also varies at different vertebral levels.  
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EPIDURAL ANALGESIA  
INDICATIONS  
1)  As an adjuvant to general anesthesia, and also to reduce the opioids 
and other analgesic requirements in the intra operative period, eg.  
x Gynaecologial surgeries  
x Abdominal surgeries 
x Thoracic surgeries  
x Orthopaedic surgeries 
x Vascular sugeries  
2)  For analgesia alone such as in Labour analgesia, where it will not 
produce motor blockade, and analgesia is not sufficient for performing 
surgery.  
3)  As a sole technique for surgical anesthesia eg. Lower segment 
caesarian sections, urological surgeries, lower limb surgeries and lower 
abdominal surgeries.  
4)  Management of chronic pain in terminally ill patients and treatment of 
back pain eg. Epidural steroid.  
5)  Postoperative analgesia after a surgery, with the help of catheter in the 
epidural space as continuous infusion or intermittent boluses.  
9 
 CONTRAINDICATIONS 
The absolute contra indications are  
x patient refusal  
x raised intracranial tension  
x infection at the site of injection  
x severe hypovolemia & shock   
x Coagulopathy  
x Severe stenotic valvular heart disease 
       The relative contraindications are  
x spine deformity    
x neurological disorders—demyelinating disease 
x sepsis 
x unco-operative patient   
x Ventricular outflow tract obstruction 
COMPLICATIONS  
• Local anaesthetic toxicity and allergy  
• Hypotension  
• Inadvertent high blockade  
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• Epidural abscess, hematoma, meningitis  
• Post dural puncture headache  
•  Anterior spinal artery syndrome  
•  Arachnoiditis  
•  Transverse myelitis  
• Catheter migration into the epidural vessels.7  
POSTOPERATIVE PAIN 
 Postoperative pain  has  deleterious effect in almost all systems of the 
body 8  
1)  In the cardio vascular system the pain causes  increase is heart rate , 
blood pressure, increase is systemic vascular resistance and cardiac 
work. This may precipitate angina and myocardial infarction in 
susceptible individuals.  
2)  In the respiratory system, hypoxia, hypercarbia, atelectasis, decreased 
vital capacity and cough to clear the secretions resulting in ventilation 
perfusion mismatch and other complications.  
3)  In the gastro intestinal system, vomiting and ileus may occur.  
4)  In the renal system, urinary retention and decreased urine output may 
occur.  
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5)  There may be an increased risk of thromboembolism due to pain and 
limited mobility.  
6)  In the endocrine system, there will be symphathetic stimulation, hyper 
metabolism and increased oxygen comsumption.  
7)  And finally, in the central nervous system anxiety, fear and fatigue 
ensues.  
ADVANTAGES OF POST OPERATIVE EPIDURAL ANALGESIA 
x The reduction in vital capacity in upper abdominal surgeries are around 
75% where as in lower abdominal surgeries it is around 50 –55%. So 
thoracic epidural analgesia provides effective pain relief thereby  
improving vital capacity  and other  pulmonary functions  .  
x In the cardio vascular system it reduces blood loss and transfusion  
requirements, reduces the incidence of angina, myocardial infarction 
and deep vein thrombosis.   
x  In the endocrine system there is reduction in the level of 
catcholamines and overall reduction in morbidity, mortality and 
duration of hospital stay.  
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PHYSIOLOGICAL EFFECTS OF EPIDURAL BLOCKADE  
The local anesthetic when injected into the epidural space acts on  the 
spinal nerve roots.9 The segmental nerve roots in the thoracic and lumbar  
regions are mixed nerves which comprises somatic sensory, motor and 
autonomic nerve fibres. Sensory  blockade leads to interruption in  the  
transmission of both somatic and visceral painful stimuli where as motor 
blockade offers muscle relaxation and there is  varying degrees of 
sympathetic blockade.  
The  injection site in epidural anaesthesia should be  as close to the 
target nerve roots as possible to obtain better results.The important concept 
for epidural anaesthesia is a differential nerve block. It means the nerve fibres 
with variable function exhibit a varying sensitivity to the effects of local 
anesthetics.   
 The order of blockade in epidural anaesthesia are sympathetic 
blockade, then pain, temperature, proprioception and subsequently motor 
blockade . Usually following an epidural block, the sympathetic blockade 
particularly temperature vary from 1-4 segments higher than the motor 
blockade, where as regression of level occurs in reverse order.  
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Effects on Cardiovascular System   
The effect on the cardiovascular system is determined by the level of 
blockade. Vasomotor tone is maintained by T5 – L1 sympathetic fibers which 
innervate vascular smooth muscles. When these fibres are blocked, arterial 
and veno dilatation with pooling of blood  and  decreased systemic vascular 
resistance occurs.  
Effects in the respiratory system:  
It has minimal effect in patients with adequate pulmonary function. 
Tidal volume, vital capacity , minute ventilation and dead space are 
unchanged.There is no alteration in pulmonary function, even with high 
thoracic blockade.   Even in intercostal  paralysis by a high thoracic block  
major alteration is hardly noticed.  
Effects in the gastro intestinal  system:  
 Due to blockade of sympathetic fibres from T5 – L1  there is  an 
unopposed vagal action leading  to increase in peristalsis and a smaller 
contracted intestines.  
Effects on renal system:  
 Epidural anesthesia has little effect on renal function due to auto 
regulation of renal blood flow, though  urinary retention is common.  
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Mechanism of Action of local anaesthetics  in the epidural space:  
In the epidural space local anesthetics  bind to sodium channels, in the  
inactivated state preventing further activation of the  channel  and 
development of action potential. They block the sodium and potassium ion 
channels in the dorsal horn and  inhibit the generation and transmission of 
pain signals and produce similar action in the ventral horn as well. In the 
spinal cord, calcium channels are blocked producing resistance to stimuli 
from nociceptive afferent neurons and there by producing analgesia. Also the 
local anaesthetics  inhibit the release of  substance P and other neuro 
transmitters like glutamate, calcitonin gene related peptide (CGRP) 
neurokinin (I& II) in the epidural space and therefore  inhibit pain signal 
transmission.  
Factors affecting the action of local anaesthetics in the epidural space:  
Site of injection:There is equal spread of local anaesthetics in the thoracic 
epidural space and cranial (or) cephalad spread in lumbar epidural space.  
Volume: 1.5 – 2ml per segment for lumbar segment and 1- 1.5ml per segment 
for thoracic segments.  
Age: In old age the inter spinous spaces become narrowed due to calcification 
of ligaments lead to reduced dose requirements.  
Weight:  Obese individuals and pregnant females require less volume because 
of space  narrowing and venous engorgement in the epidural space. 
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Height:Shorter individuals require lesser volume.  
Alkalinisation of local anesthetics :Alkalinisation potentiates the onset of 
action.  
Posture has little effect.  
Adjuvants : Addition of adjuvants enhance the quality of blockade, eg. 
opioids, alpha2 agonist, ketamine etc.  
COMMON TECHNIQUES OF EPIDURAL BLOCK   
   Usually in sitting or lateral decubitus position, through midline (or) 
paramedian approach.10  
Various needles used are11 
1. Crawford point needle 
2. Tuohy Huber point needle – It has a blunt leading edge and a 
lateral opening at the tip. This needle is a standard directional 
needle used for epidural anaesthesia. 
3. Hustead Needle – It is a modified Tuohy  needle with a rounded 
tip and a bevel opening which is located 2.7 mm from the tip in 
the 18G needle. The advantage of this needle is the lower 
incidence of catheter shearing.  
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Figure 3: Tuohy needle 
   
 
Figure 4: Various types of epidural needle 
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Various methods of identifying epidural space:  
• Loss of resistance technique.It is the most commonly used method. LOR 
with air (or) saline and  the test is called as whoosh test, but there is risk of air 
embolism in Children.12,13  
• Hanging drop method 14 
• Recently a pressure transducer used saline filled sterile tubing is connected 
to the epidural  needle,and if the needle tip  enters into the space, the pressure 
will drop suddenly. This is useful in obese  patients and identifying epidural 
space in the cervical region.This is called as epidural space identifier.  
• Modified drip method (1991)  
• Macintosh epidural balloon (2008)  
• Epidrum (it  is an optimal pressure loss of resistance device) (2011)  
•  Neuraxial ultrasonography recently developed for identification of epidural 
space (2010).        
• Epiduroscopy.      
TECHNIQUE 
Loss of resistance (LOR) is the most common technique used to 
identify the epidural space. A 5ml syringe containing air or saline is attached 
18 
to the Tuohy needle. The needle is advanced with the left thumb and index 
finger with the back of the hand held against the back of the patient. Pressure 
is now applied on the plunger with the thumb of the right hand and 
maintained as the needle is further advanced.  
 
Figure 5: Epidural space 
Having  passed through skin, subcutaneous tissue, supra spinous 
ligament, inter spinous, as soon as the ligamentum flavum is pierced, 
resistance to syringe plunger is lost and the epidural space is entered. This 
secure grip of the epidural needle to maintain its position in the epidural space 
is called the “Bromage grip”.  
TEST DOSE15 
x Ideal test dose contains 5mcg of 1:200,000 adrenaline each ml of LA. 
x It  identifies both intravascular and intrathecal placement 
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x Effective doses of local anaesthetic solution 
o lignocaine - 45mg 
o bupivacaine - 15mg 
o ropivacaine - 16mg 
x Criteria for positive epinephrine test (ASRA 2001) 
Patient <60 years not on beta 
blockers  
HR increase > 20 bpm 
SBP increase > 15mmHg 
Patient  < 60 years on beta 
blockers 
SBP increase >15 mmHg 
Age > 60 years HR increase > 9bpm 
SBP increase >15mmHg 
Under GA HR increase >8bpm 
SBP increase > 13mmHg 
 
Table 1: ASRA Criteria: Local anaesthetic test dose 
 
x Intrathecal placement is identified by the presence of motor blockade 
involving the great toe. 
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ULTRASONOGRAM 
Ultrasonogram is based upon the principle of piezoelectric effect.16  
•  In 1880, the principle of piezoelectric effect, using natural 
quartz was discovered by the Curies  
•  Applied in use for Diagnostic Medical applications since late 
1950 .John Wild first used ultrasound to access the thickness of 
bowel .He has been considered as the father of medical 
ultrasonography 
•  Medical ultrasound imaging uses frequency ranging from 2-15 
MHz 
x Diagnostic Ultrasound is recognised as safe, effective, and 
highly flexible form of imaging modality . 
x Compared to other prominent imaging modalities  it provides  
images in real time, it is portable and can be used at bedside 
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Figure 6: Ultrasound machine 
PIEZOELECTRIC EFFECT  
 Piezoelectric Effect is defined as the principle of converting electrical 
energy into mechanical energy. The reverse of the piezoelectric effect 
converts the mechanical energy back to electrical energy.   
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 ULTRASOUND TRANSDUCERS  
•  A transducer is a device that converts one type of energy into 
another.  
•  Based upon the pulse-echo principle, transducers convert:  
a. Electrical energy into sound called pulse  
b. Sound into electrical energy called echo     
PULSE  
•  Pulse is the sound wave which is sent to the soft tissues. 
Interaction of this sound wave with soft tissue is called “bio 
effect”. Pulsing is done by the transducer or probe crystals and 
is not under operator control.   
ECHO  
•  Echo is wave produced by the soft tissues and these waves are 
received back by the transducer crystals which are then 
processed and interpreted by the USG machine.   
FREQUENCY  
•  Number of complete cycles per unit of time  
•  One cycle per second is one Hertz (Hz)  
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•  Commonly used transducer frequencies are:  
•  2.5 – 3.5 MHz – for abdomen, obstetrics and gynaecology  
•  5.0 – 7.5 MHz – for breast, thyroid  
•  7.5 – 10 MHz – for superficial veins, superficial structures  
  High frequency gives17  
– Improved resolution with less depth of penetration  
– Used for superficial structures  
  Low frequency gives   
– Poorer resolution with full depth of penetration  
– Used for general abdomino-pelvic structures  
Transducer frequency in ultrasound machine is predetermined by 
design.    
WAVELENGTH  
•  It is the distance between consecutive cycles of sound.   
BANDWIDTH  
•  A range of frequencies is called bandwidth. Broad bandwidth 
transducer comprises of more than one operating frequencies.  
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AXIAL & LATERAL RESOLUTION  
•  Spatial Resolution defines how physically close two objects can 
be yet displayed separately.  
–  Axial: along the path of beam  
–  Lateral: perpendicular to the path of beam   
•  Normally used spatial resolution is1.0 mm or less.   
MACHINE COMPONENTS  
The USG machine has the following components 
1. TRANSDUCER 18   
Types:  
• Mechanical  
– Oscillating  
– Rotating  
• Electronic  
– Linear Arrays  
– Curved Arrays  
– Phased Arrays  
2. RECEIVER  
3. MEMORY  
4. DISPLAY   
25 
                 
 
Figure 7: Components of a transducer 
FIELD OF VIEW SHAPES  
Sector FOV   
• Produced by oscillating/ rotating curved arrays, phased arrays  
• Typically used in cardiac and abdominal application   
Linear FOV   
•They are produced by linear arrays  
• Classically used in superficial application   
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PROBE TYPES   
¾ Curvilinear: They are Low Frequency Probe  
 
 
 
 
 
Figure 8: Curvilinear probe 
   
¾ Linear: They are  High Frequency Probe 
                                  
                                 
 
 
Figure 9: Linear probe 
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 DISPLAY MODES  
• B Mode - 2 dimensional  
 
Figure 10: B mode image 
 
• M Mode - records moving echoes from the heart in display, thus 
the motion could be interpreted in terms of myocardial and valvular 
function.  
 
 
 
 
 
Figure 11: M Mode image 
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• Doppler - here the frequency shift in echo is measured after a 
certain time.   
 
 
 
 
 
Figure 12: USG Doppler image 
• Colour Doppler - uses colour corresponding to frequency shift; 
red for near to and blue for away from the probe.   
 
 
 
 
 
Figure 13: USG Colour Doppler image 
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RECTUS SHEATH BLOCK – CLINICAL ANATOMY & 
TECHNIQUES 
         Schleich first described the use of rectus sheath blocks (RSB) in 1899, 
with the aim of providing muscle relaxation and analgesia of the anterior 
abdominal wall by blocking the terminal branches of the thoracolumbar 
nerves within the substance of the rectus abdominis muscle (RAM).19        
             It was originally performed as a blind, loss-of resistance technique.  
RSB had previously been under-utilized, largely due to concerns over the 
precision of needle-tip placement, mainly in relation to vascular structures 
contained within the rectus sheath as well as visceral structures within the 
underlying peritoneal cavity. 
                RSB is ideally suited for ultrasound guidance because the RAM, 
layers of the rectus sheath, and important vascular structures are easily and 
accurately identified with ultrasound technology. Rectus Sheath Catheters are 
designed to be an alternative to epidural analgesia or opioid based IV-PCA by 
targeting the anterior branches of the intercostal, segmental nerves which 
supply the abdomen. 
x S.M.Yentis described the usage of single injection bilaterally into 
rectus sheaths for midline incisions for gynaecological surgery which 
decreased the opioid requirement.20 
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x P.Cornish and A.Deacon first described the technique of surgically 
placed rectus sheath catheters for pain relief in upper abdominal 
surgery to decrease perioperative opioids.21  
x H.Willschke  described the technique of USG guidance for rectus 
sheath blocks in children submitted for umbilical hernia repair.22 
x D.J.Sandeman and colleagues described the procedure of rectus sheath 
catheter placement using USG-guidance.23 
Clinical Anatomy 
          
 
Figure 14: Nerve supply to the abdominal wall 
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 Anatomical course of the thoracolumbar nerves, the sensorimotor 
innervation of the anterior abdominal wall is supplied by the ventral rami of 
the thoracolumbar spinal (T7-L1) segmental nerve.  The thoracolumbar 
nerves course along the anterolateral wall within the transversus abdominis 
plane (TAP), and continue anteromedially within the TAP, eventually 
encroaching upon the lateral aspect of the rectus sheath.  The nerves then 
enter the lateral aspect of RAM and contribute to the formation of a nerve 
plexus that runs craniocaudally within the muscle in close proximity to the 
lateral branch of deep epigastric artery. 
            The thoracolumbar nerves typically pierce the posterior border (89%) 
and less commonly the lateral border (11%) of the RAM, with the nerves 
piercing the posterior border within 1.6 to 2.6 cm from the lateral edge of the 
RAM.  The nerves provide both muscular and cutaneous branches to 
innervate the muscle fibres and overlying skin.  Notably, the branches of the 
thoracolumbar nerves do not cross midline.              
Anatomy of the Rectus Sheath24   
         The rectus sheath is formed from the aponeuroses of the fascial 
sheaths of all three lateral abdominal wall muscles. 
x External oblique (EOM), 
x  Internal oblique (IOM), and 
x  Transversus abdominis (TAM) muscles  
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Figure 15: Anatomy of rectus sheath 
 
             Each of these muscles form a bilaminar aponeurosis at its medial 
border converging to form the lateral border of the RAM, termed the Linea 
Semilunaris.  The anterior and posterior lamina of the EOM and the anterior 
lamina of the IOM fuse together and continue further medially over the 
ventral surface of the RAM to form the anterior part of the rectus sheath.  
Similarly, the posterior lamina of the IOM and anterior and posterior lamina 
of the TAM fuse together and continue medially dorsal to the RAM to form 
the posterior part of the rectus sheath.  At the medial border of the RAM, the 
anterior and posterior portions of the rectus sheath come together, with the 
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fibres coursing further medially towards the medial border of the contralateral 
RAM forming the midline linea alba.  
        The anterior part of the rectus sheath extends along the entire vertical 
length of the RAM.  In contrast, the posterior part of the rectus sheath extends 
only along the upper two-thirds of the RAM.  In the lower one-third, the 
posterior part of the rectus sheath stops approximately midway between the 
umbilicus and symphysis pubis.  At this anatomical transition point, the 
aponeuroses that had formed the posterior portion of the rectus sheath now 
also course over the ventral surface of the RAM.  This transition point is 
known as the arcuate line.  The transversalis fascia is a thin layer of 
connective tissue located just deep to posterior part of the rectus sheath.  
Located just deep to the transversalis fascia is the parietal peritoneum.  
Inferior to the arcuate line, the transversalis fascia is located immediately 
deep to the posterior border of the RAM.  The use of USG guidance increases 
the success rate of the block, lowers the dose of local anaesthetics, and 
thereby reduce the complications because of constant visual confirmation. 
Also, ultrasound guidance avoids the need for surgical placement of catheters 
intraoperatively which would be difficult to place without significant surgical 
dissection in the rectus sheaths. Rectus sheath catheter, is a regional 
anaesthesia technique that provides analgesia to the parietal peritoneum, as 
well as skin and muscles of the anterior abdominal wall. 
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SONOANATOMY AND TECHNIQUE  
Short-Axis In-Plane Approach   
x The transducer, high frequency linear array is positioned just lateral to 
the umbilicus in an axial (transverse) plane. Identify the layers of the 
anterior abdominal wall from superficial to deep. A layer of 
subcutaneous adipose tissue that will vary in depth depending on body 
habitus. 
x  Deep to the subcutaneous tissues will be the anterior portion of the of 
the rectus sheath (a horizontal bright hyperechoic linear structure 
extending from lateral to medial). 
x  Deep to the anterior rectus sheath is the RAM (relatively hypoechoic 
when compared to the rectus sheath).  
x Deep to the RAM will be the posterior portion of the rectus sheath (a 
horizontal bright hyperechoic structure extending from lateral to 
medial). The deep superior (above the umbilicus) and inferior (below 
the umbilicus) epigastric arteries may be seen as small, pulsatile, 
anechoic structures located in the deepest aspect of the RAM.  Colour 
flow Doppler may confirm the presence of blood flow within the 
arteries. 
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x   Deep to the posterior portion of the rectus sheath will be the 
transversalis fascia (a hyperechoic linear structure).   
x Deep to the rectus sheath and transversalis fascia is the peritoneal 
cavity, which is identified by the presence of peristaltic movements of 
the bowel loops.  
x The target site for local anaesthetic deposition is deep to the RAM, but 
superficial to the posterior aspect of the rectus sheath.  The terminal 
thoracolumbar nerves are too small to be visualized as discrete 
structures; thus, RSB is a “compartment block.”  
x  Transducer position and initial needle insertion site (lateral to the 
transducer) should be adjusted in a cephalad-to-caudal manner based 
on the anticipated location of the vertical midline incision.  Placing the 
transducer in the middle of the anticipated vertical extent of the 
midline incision should optimize distribution of local anaesthetic 
spread.   
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Figure 16: rectus sheath block 
Single Injection Technique   A 21-gauge, 100 mm (or 20-gauge, 150 mm) 
needle is inserted 3-8cm lateral to the lateral edge of the transducer and 
guided “in-plane”. The needle is advanced in-plane from lateral to medial and 
superficial to deep.  
The needle should penetrate through the lateral aspect of the linea 
semilunaris and enter the lateral aspect of the RAM.  The needle is further 
advanced until it is positioned deep to the potential space between the 
posterior border of the RAM and the posterior  rectus sheath.25  
 This target site is referred to as the “Posterior Rectus Sheath 
Compartment.”  At this point, a small (1-3 ml) volume of local anaesthetic (or 
sterile saline) is injected to confirm correct placement within the posterior 
rectus sheath compartment, indicated by the appearance of an anechoic fluid 
collection.   Subsequently, 15-20 ml of local anaesthetic is incrementally 
injected while observing for the expanding anechoic fluid collection.   
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As the local anaesthetic is injected, it will often result in clear 
separation of the deep border of the RAM from the posterior rectus sheath. 
Improved local anaesthetic spread may be facilitated by advancement of the 
needle further medially as the anechoic fluid collection visibly expands the 
posterior rectus sheath compartment in a lateral-to-medial fashion.   After 
local anaesthetic injection, the transducer is moved in a cephalad-to-caudal 
fashion to visualize the spread within the posterior rectus sheath 
compartment. The same procedure is repeated on the contralateral side.26  
 
Figure 17: rectus sheath block, single injection technique 
Continuous Catheter Technique27 
 •  If a continuous catheter technique is desired, the same steps as 
above are followed except that a 16-gauge  Tuohy  needle is used and 
following fluid  expansion of the posterior rectus sheath compartment, an 18-
gauge  catheter is threaded 4-6 cm beyond the needle tip 
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Figure 18: rectus sheath block; continuous catheter technique 
 
 The location of the catheter tip may be confirmed by direct 
visualization of the catheter or by visualization of local anaesthetic spread 
within the posterior rectus sheath compartment following the injection of 
local anaesthetic through the catheter. The needle is withdrawn and the 
catheter is secured to the skin and covered with a sterile clear transparent 
dressing.28 
 Local Anesthetic Selection  
x 15-20 ml ropivacaine 0.25% with 1:400,000  epinephrine  
x 15-20 ml bupivacaine 0.25% with 1:400,000 epinephrine per side  
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x For paediatric patients, the suggested dosing is 0.5 ml/kg (either 
bupivacaine 0.25% or ropivacaine 0.25% with epinephrine 1:400,000) 
per side.   
Adding epinephrine decreases the local anaesthetic peak plasma 
concentration (C max), because spread of local anaesthetic will encompass a 
relatively large surface area for systemic absorption.  Based on initial 
pharmacokinetic studies, the time to peak plasma concentration (T max) is 
approximately 45 minutes. Thus, the patient need to be observed for potential 
signs or symptoms of local anaesthetic systemic toxicity for a minimum of 45 
minutes after completion of RSB.  
           The expected duration of RSB is approximately 6-10 hours.  Thus, 
there should be an analgesic plan when the analgesic effects of the single shot 
RSB wears off.  
          For a continuous catheter technique, a small continuous infusion (2-3 
ml/hr) is recommended simply to keep to catheter tip patent.  Intermittent 
bolus injection of 10-20 ml ropivacaine or bupivacaine 0.25% per side every 
6-10 hours is recommend to maintain postoperative analgesia. 
Complications of rectus sheath block:  
x Infection 
x Rectus sheath hematoma 
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x Inadvertent intravascular injection 
x Bowel injury 
x Local anaesthetic toxicity 
        Strict aseptic precaution, ultrasound guidance and careful monitoring of 
signs of intravascular placement will reduce the risks of rectus sheath block. 
 Current Role of Ultrasound-Guided RSB  
°  RSB may be performed prior to the surgical incision to facilitate 
analgesia immediately after initiation of surgery. They will decrease 
intraoperative analgesic (opioid) requirements if they are placed before 
incision. 
 °  Alternatively, RSB may be performed in the immediate postoperative 
setting as a “rescue block technique” in the event of either unexpected 
severe postoperative pain after an abdominal surgical procedure or 
unanticipated failed epidural analgesic technique.  
°  One of the primary indications for RSB with or without catheters   is to 
provide postoperative abdominal wall analgesia when thoracic epidural 
analgesia (TEA) is contraindicated.  One potential advantage is the 
notable lack of sympathectomy (and hypotension) that is commonly 
associated with TEA.29 
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PHARMACOLOGY OF BUPIVACAINE  
 Bupivacaine is an amide local anaesthetic formed by addition of butyl 
group to the piperidine nitrogen of mepivacaine. It was synthesized by 
A.F.Ekenstam in 1957 and came into clinical use since 1963. It contains equal 
proportions of ‘S’&‘R’ enantiomers and thereby a racemic mixture is 
obtained.  
Chemical Structure  
 
Figure 19 : Structure of Bupivacaine 
1- butyl N- (2, 6 dimethyl phenyl) -2-piperidine 
dacarboxamide hydrochloride monohydrate  
Physicochemical Profile 
x Molecular weight - 288. 
x  pKa - 8.1. 
x Plasma protein binding - 95% 
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x Lipid solubility - 28. 
x Vd – 71 litres 
x Clearance - 0.472 litres/min  
x Onset - Slow  
x Duration - 240 – 480 min 
x Toxic plasma concentration - 240-480min 
x Elimination Half Life - 210min  
Mechanism of action:  
¾ They produce conduction blockade by selectively binding to alpha 
subunit of sodium channel, in an activated closed state, and prevent 
their change to rested closed   and  activated  open state there by 
preventing the conduction of impulses and  action potential.   
¾ In addition to sodium channels  bupivacaine blocks voltage dependent  
Potassium channels and this leads to broadening of action potential.  
¾ Bupivacaine also blocks the L type calcium channels.  
¾ In addition bupivacaine blocks both types of pain fibres myelinated A 
– Delta and C fibres. Preganglionic-B fibres are readily blocked by 
local anaesthetics. 
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Pharmacodynamics  
 Bupivacaine has a stabilizing action on all the excitable membranes. 
So in the cardio vascular system it causes a reduction in automaticity and in 
the nervous system restlessness, tremors and convulsions occur on over 
dosage. It is more potent than lignocaine, the sensory blockade is more than 
the motor blockade.30  
Pharmacokinetics  
Bupivacaine is a weak base that has a pKa value above the 
physiological pH and therefore only a small fraction of the drug is in ionized 
form. It is rapidly absorbed from the site of injection. Plasma concentration 
depends on the route of administration (5 -30min), distribution and rate of 
clearance. The lungs are capable of extracting bupivacaine from the systemic 
circulation and its first pass pulmonary extraction is dose dependent. 
Metabolism 
Bupivacaine binds to the plasma protein alpha-1-acid glycoprotein.   It 
undergoes aromatic hydroxylation, N dealkylation, amide hydrolysis & 
conjugation. Pipecolylxylidine is the product of metabolism. Renal diseases 
will not affect the kinetics of bupivacaine as only < 10 -15% of the drug is 
excreted unchanged in urine.  
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Uses of bupivacaine31  
• For central neuraxial block (Spinal epidural and caudal)  
• Peripheral nerve block   
• Infiltration anaesthesia  
Preparations available  
0.25%, 0.5% in vials (10ml) (20ml) 5mg/ml + dextrose in 4ml 
ampoules,   
Maximum permitted dose 3mg/ml for 0.25 - 0.5% Bupivacaine  
Maximum 400mg/ 24 hours    for   0.75% Bupivacaine 
Maximum 20 mg    for    0.5% Hyperbaric Bupivacaine 
Side effects  
• Allergy  
• Pruritus 
• Urticaria  
• Angioneurotic edema  
• Accidental intravascular injection.  
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• CNS toxicity:  
o tinnitus 
o vertigo 
o drowsiness  
o muscle twitches,  
o slurred speech,  
o seizures  
o Coma.  
• Cardiac toxicity:  
o Hypotension  
o Arrhythmia  
o Atrioventricular block  
o Ventricular tachycardia   
o Ventricular fibrillation  
 • Hepatotoxicity   
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REVIEW OF LITERATURE 
1) Bashandy et al, 2014 32           
In this study Bashandy observed the efficacy of a pre-emptive single-
injection rectus sheath block in providing better postoperative pain scores 
compared to general anaesthesia alone. 
Sixty patients undergoing midline abdominal surgeries were included 
in this randomized controlled study. The patients were allocated into two 
groups: RSB group had a rectus sheath block just after induction of 
anaesthesia and before the surgical incision, and general anaesthesia group 
had general anaesthesia alone. Visual analogue scale score (VAS), opioid 
requirement and hemodynamic parameters in the postoperative period were 
compared in the two groups for 48 hours. 
Results showed the median VAS score to be significantly reduced in 
RSB group compared with GA group in the postoperative period (P ޒ 0.05).  
Morphine consumption was much lower in RSB group than GA group patient 
in the first two postoperative days 
 The study concluded that Ultrasound-guided rectus sheath block is an 
easy technique to learn. This technique, when used with general anaesthesia, 
is an effective means of decreasing pain scores and opioid requirement 
compared with the general anaesthesia alone. 
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2) Manassero et al, 2015 33 
This study was a prospective study conducted to examine the local 
anaesthetic (LA) spread and its effectiveness for surgical anaesthesia of rectus 
sheath block (RSB) under ultrasound guidance, in adult patients undergoing 
umbilical hernia repair. 
30 patients received a bilateral US-guided injection of 20 ml 
levobupivacaine 0.375% + epinephrine 5 ȝg/ml at T-10 level. Anaesthetic 
spread into the rectus sheath was evaluated using ultrasound at T-9  and  T-11 
levels and scored from 0 to 4. The RSB was defined effective for surgical 
anaesthesia if it was able to produce an anaesthetic level sufficient for surgery 
without any mepivacaine supplementation. 
 Results showed that the block was effective for surgical anaesthesia in 
53.3% of patients (95% confidence interval, ±17.8). In the remaining patients, 
anaesthesia supplementation was needed at cutaneous incision, whereas 
manipulation of the muscle and fascial planes was painless. No patients 
required general anaesthesia. LA spreads as advocated (to T-9 and to T-11 
bilaterally = spread score 4) in 8/30 patients (26.6%); in these cases, the block 
was 75% effective for surgery. The anaesthetic spread was most negatively 
influenced by increased body mass index. Postoperative analgesia was 
excellent in 97% of patients. 
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The study was concluded that the use of RSB as an anaesthetic 
management of umbilical hernia repair is recommended with an anaesthetic 
supplementation at the incision site. 
3) Wilkinson et al, 2014 34 
         Rectus sheath block using rectus sheath catheter may provide a 
newer approach to somatic pain without the related adverse effects of epidural 
analgesia. The trial aimed at comparing the effectiveness of these two 
techniques in terms of analgesia, patients’ overall experience, postsurgical 
functional recovery, cost-effectiveness and safety. 
         The study was a single-centre randomised controlled non-blinded 
trial, which included qualitative study. Over a period of two-years, 132 
patients undergoing abdominal surgery through a midline incision were 
randomised to receive either Epidural analgesia or rectus sheath block for 
post-operative pain relief. The primary outcome was to enumerate pain scores 
using VAS on movement from lying to a sitting position at the end of 24 
hours postoperatively, and the overall patient experience between the groups 
were evaluated. Secondary outcomes comprise pain scores at rest and on 
movement at various time intervals, opioid requirement and functional 
recovery.  
      This randomised controlled trial comparing epidural analgesia to USG 
guided rectus sheath catheters in adults undergoing midline laparotomy is 
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underway. This a comparison between these pain packages and not just two 
analgesic approaches, in order to establish if rectus sheath catheter is a viable 
alternative to epidural analgesia. 
4) Dilek Ozcengiz et al, 2012 35 
         In paediatric patients regional techniques are gaining popularity and 
are used in surgeries such as repair of umbilical and epigastric hernia, 
laparoscopic surgery and other surgeries involving midline incisions to 
provide adequate analgesia. 
            The aim of this study was to assess the effectiveness and side effects 
of the rectus sheath block with a control group that received intravenous 
tramadol, for analgesia after major abdominal surgery in paediatric patients.  
Sixty children who underwent laparotomy were included in this study. 
Patients were divided in two groups of 30 each: group R patients who had 
rectus sheath block with 0.25% levobupivacaine and group T, control patients 
who received intravenous tramadol with normal saline injections into rectus 
sheath. CHEOPS scale for pain assessment and sedation scores were 
enumerated at 5, 15, 30, 60 minutes and 2, 6, 12, 24 hours.  
              Results showed the mean total tramadol used by the levobupivacaine 
and the normal saline groups in the first 24 h were 0.95 mg/kg and 4.07 
mg/kg. There was no significant difference between the groups in terms of 
CHEOPS pain score and sedation score. In terms of postoperative nausea and 
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vomiting, analgesic consumption and the analgesic duration the rectus sheath 
block was superior to intravenous tramadol in children undergoing major 
abdominal surgery .  
5) Willschke et al, 2006 36 
            The purpose of this study was to evaluate anatomically and clinically 
the ultrasound-guided rectus sheath blocks in children. A total of 30 children 
were included in the sonoanatomical part of the study. After induction of 
general anaesthesia children received a rectus sheath block under real-time 
USG guidance by injecting 0.1 ml /kg of 0.25% levobupivacaine on both 
sides in the space between the posterior rectus sheath and the rectus muscle. 
       Visualization of the posterior rectus sheath using ultrasound was clearly 
possible in all the children. The association between the depth of the posterior 
rectus sheath to the weight, height and body surface area was poor. The 
ultrasound guided rectus sheath block provided adequate analgesia in all 
children and no additional analgesia was required in the perioperative period.  
         The study concluded that the bilateral rectus sheath using 0.25% 
levobupivacaine 0.1 ml/kg under ultrasound guidance provides appropriate 
analgesia for umbilical hernia repair. The depth of the posterior rectus sheath 
which was highly unpredictable in children favours the use of real time 
ultrasound in rectus sheath block. 
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6) AR Godden et al, 201337 
          Epidural analgesia has been the accepted gold standard modality for 
postoperative analgesia in open abdominal surgery. Yet, there is significant 
risk associated with epidural analgesia. The study was a retrospective analysis 
aimed to review the effect of EA (Epidural Analgesia) and ultrasound guided 
rectus sheath catheters (RSC) on analgesia and postsurgical complications 
following open colorectal cancer surgery.  
           A three-year retrospective review of case details was undertaken of all 
patients who underwent open colorectal cancer surgery who had either EA or 
RSC for postoperative pain relief. 
           The case notes of 120 patients were reviewed retrospectively: 85 
patients had EA and 24 RSC while 11 patients were excluded from the study. 
The EA group experienced a significantly higher incidence of hypotension 
than the RSC group on the first postoperative day (p=0.0001). Statistically 
there was no significant variations in pain scores or opioid sparing properties 
between the two groups (p=0.92). There was no difference in postoperative 
pulmonary infection, wound infection or anastomotic leaks between the 
groups. The RSC group had a higher incidence of postoperative ileus than the 
EA group. However, the sample size were too small to draw a reliable 
conclusion.  
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   The study concluded that the use of ultrasound guided RSC 
demonstrated effective postoperative analgesia equivalent to EA with the 
potential benefits of a reduced incidence of hypotension.  
7) Wilkinson KM et al 2014 
Rectus Sheath Catheters (RSC) allow infiltration of local anaesthetic 
into the posterior rectus space. This provides analgesia for midline incisions 
without the side effects associated with other forms of pain relief.  
Wilkinson presented a case of RSC use following emergency surgery.  
A 53-year old woman presented with small bowel obstruction. She developed 
SIRS with lactic acidosis and an acute kidney injury. Emergency laparotomy 
and bowel resection were performed. Postoperatively the patient remained 
unstable and was transferred to the intensive care unit for overnight 
ventilation. The following morning, hemofiltration was instituted due to 
anuria and rising creatinine. Heparin was used for anticoagulation. A decision 
was taken to utilise RSC for post-operative analgesia and these were inserted 
under ultrasound guidance. An initial bolus of 40ml of 0.375% bupivicaine 
was followed by 0.2% ropivicaine via a pump (10mls/hour with an additional 
PCA bolus of 10mls available 4-hourly). 10mgs of intravenous morphine was 
then given to cover any visceral pain, sedation was discontinued and the 
patient was successfully extubated one hour later. Regular paracetamol and a 
25ȝg fentanyl patch were also prescribed. Results Analgesia was excellent-the 
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maximum recorded pain score with the catheters in situ was 2/10. A single 
adjuvant dose of iv morphine was required on day 3. Recovery progressed 
well and the RSC were removed on day 4.  
      This case highlights several contraindications including sedation, 
haemodynamic instability, infection and coagulopathy. Opiate-based regimes 
can also be used after emergency surgery. However, systemic opiates have 
been shown to be less effective than epidurals and are associated with a 
higher incidence of complications such as ileus. The choice of analgesic 
regimen after emergency laparotomy can be difficult, but this case highlights 
that RSC can be a safe and effective option. 
8) Wada M et al,2012 38 
A rectus sheath block provides postoperative pain relief for midline 
abdominal incisions. However, there is a lack of details about the 
pharmacokinetic effects of local anaesthetic used in such type of blocks. In 
this study, the time course of ropivacaine concentrations after rectus 
sheath block is studied. 39 patients undergoing elective lower abdominal 
surgery were allocated to three groups receiving rectus sheath block with 20 
mL of different concentrations of ropivacaine. Peak plasma concentrations 
were dose dependent, and there were no significant differences in the times to 
peak plasma concentrations. The present data also suggested a slower 
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absorption kinetics profile for ropivacaine after rectus sheath block than other 
compartment block. 
9) Yakoshi et al 2014 39 
       The study was conducted to assess the analgesic effectiveness and 
safety of rectus sheath block combined with intraperitoneal instillation using 
two doses of ropivacaine in patients undergoing laparoscopic gynecological 
surgery. 
53 consenting women were randomized to receive intraperitoneal 
infiltration with 0.25% ropivacaine or 0.5% ropivacaine followed 
by rectus sheath block with 0.375% ropivacaine. The outcomes of clinical 
safety were measured using plasma concentration of local anaesthetics and 
occurrence of any toxic symptoms. The analgesic efficacy was assessed by 
using VAS score for pain and morphine consumption in the first 24 hours 
postoperatively. 
Result showed patients' baseline characteristics, surgical factors, and 
analgesic outcomes were comparable between the two groups. Although peak 
plasma concentration of ropivacaine was significantly higher in patients 
receiving 0.5% ropivacaine, but none of the analysed concentrations were 
above the toxic limits. Besides, no patients showed any symptoms of local 
anaesthetic toxicity. 
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The study showed that the combination of rectus sheath block with 
intraperitoneal instillation of ropivacaine was safe and potent enough in 
relieving postoperative pain after laparoscopic surgery. 
10) Osaka et al, 2011  
Obstructive ileus is a life-threatening gastrointestinal condition that 
requires emergency surgery. Patients with obstructive ileus may develop 
coagulopathy. In such cases, central neuraxial blockade should be 
avoided. Rectus sheath blockade (RSB) is one of the popular methods for 
abdominal wall surgery. Ultrasound imaging of the rectus sheath may 
facilitate successful RSB by indicating the presence and location of rectus 
abdominis. Two patients presented with ileus secondary to rectal or sigmoid 
cancer and underwent emergency ileostomy. The patients had mild 
coagulopathy [platelet count, 77,000 /ml3 in case 1, and platelet count, 98,000 
ml3 in case 2]. Each patient underwent general anaesthesia using propofol and 
remifentanil. They were given 0.5% ropivacaine 20ml for RSB under 
ultrasound-guidance. Their hemodynamics was stable and they did not need 
another muscle relaxant during operation, except succinylcholine during 
induction. RSB is useful for abdominal operations. In addition, 
ultrasonograhphy facilitates the prediction of depth of the 
posterior rectus sheath and improves the accuracy of local anesthetic 
placement. We conclude that RSB is effective for improving postoperative 
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pain and intraoperative muscle relaxation of the abdominal wall. Ultrasound-
guided RSB is an alternative method to central neuraxial blockade. 
11) Thomas J Dutton et al, 2014 40 
This study was  conducted in patients undergoing open midline urological 
surgeries to study the safety and efficacy of rectus sheath blocks by placing 
bilateral rectus sheath catheters. 
 Under ultra  sound guidance rectus sheath catheters were placed in 200 
patients for whom 106 patients underwent radical retropubic prostatectomy( 
RRP ) and 94 underwent open radical cystectomy. 
 Retrospective review was undertaken, outcomes included technical 
success and complication rates of the insertion and use of RCS, visual 
analogue score, additional analgesia requirement and length of hospital stay. 
Result showed all RCS were successfully placed without complications and 
though overall pain scores in both the groups. 
 The study concluded that the use of RCS appear to be effective and 
safe method of perioperative analgesia in patients undergoing major open 
urological surgeries. 
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MATERIALS AND METHODS 
This study was conducted at Government Stanley Medical College 
hospital, Chennai on 100 patients who underwent midline laparotomy 
surgery. This study was conducted after obtaining approval from the 
institutional ethical committee. Patients were explained about the procedure in 
detail and informed written consent was obtained for the same. 
Study Design: 
 This study is a randomized prospective interventional clinical trial. 
Randomisation was done by allocating the patients to either the Rectus Sheath 
Block group (Group RSB) or Thoracic Epidural Analgesia group (Group 
TEA) by draw of lots. Study was an observer blinded study. The patients who 
met the inclusion and exclusion criteria were only included in the study. 
Patients were divided into two groups of 50 each.  
Group RSB: Patients receiving Rectus Sheath Block 
Group TEA: Patients receiving Thoracic Epidural Analgesia. 
SAMPLE SIZE:   
 t tests - Means: Difference between two independent means (two 
groups) Analysis: A priori: Compute required sample size 
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 Input: Tail(s) = Two  
Effect size d = 0.57  
Į err prob = 0.05 Power 
 (1-ȕ err prob) = 0.80  
Allocation ratio N2/N1 = 1 
 Output: Non-centrality parameter į = 2.8500000   
Critical t = 1.9844675 
 Df = 98  
Sample size group 1 = 50  
Sample size group 2 = 50  
Total sample size = 100  
Actual power = 0.8056577 
Sample size was drawn using the above observation.50 patients in each 
of the two groups: Group RSB and Group TEA were included.  
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SELECTION OF CASES: 
Inclusion Criteria: 
All consented patients with  
x Age: 18 to 65 years  
x Both genders 
x Weight:  50 Kg 
x ASA: 1, 2 and 3. 
x Midline laparotomy surgery 
Exclusion Criteria: 
x Patients with known hyper sensitivity to local anaesthetics.  
x Patient refusal 
x Abnormal coagulation status 
x Severe systemic illness 
x Planned transverse or oblique abdominal incision 
x Skin lesion at site of blockade 
x Pre-existing chronic pain abdomen 
x Pregnancy 
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Material Required: 
x Monitor: NIBP, ECG, Pulse oximeter. 
x Resuscitation drugs and equipment. 
x Anti-septic skin preparation and sterile gloves. 
x Ultrasound machine (eSOATE) with high frequency (6-12 MHz) linear 
probe. 
x Ultrasound gel. 
x Epidural needle/catheter set. 
x 2 ml, 5ml, 10ml syringes. 
x Adhesive tapes. 
x Drugs: 
o Injection Midazolam 
o Injection Glycopyrrolate 
o Injection Fentanyl 
o Injection Propofol 
o Injection Vecuronium 
o Injection Neostigmine 
o Desflurane 
o Injection Bupivacaine 0.5% plain 
o Injection Tramadol 
o Injection Ondansetron 
61 
STUDY METHOD 
Procedure: 
All the patients subjected to study were assessed in our pre-anaesthetic 
assessment clinic. Patients satisfying the inclusion criteria were only included 
in the study. Written informed consent was obtained from the patient. 
Patients were randomly allocated into 2 groups, each group comprising 
of 50 patients. Randomization was done by draw of lots by allocating patients 
either to group RSB (rectus sheath block) or group TEA (thoracic epidural 
analgesia).  
         On the day of surgery patient was shifted to the pre medication room. 
18 gauge IV line was secured and ringer lactate was started at 2ml /kg /hr. 
Patient was given premedication with Inj. Glycopyrrolate (0.05 mg/kg) IM 
and injection midazolam (0.05 mg/kg) IM. Patients were connected to the 
monitors NIBP, ECG, SpO2 after shifting the patient to the Operation 
Theatre. All the baseline hemodynamic parameters were noted. 
STANDARD GENERAL ANAESTHETIC 
          All patients in the trial received a general anaesthetic as follows: Inj. 
Fentanyl 2mcg/kg IV; Inj. Propofol 2 mg/kg; Inj. Vecuronium 0.1 mg/kg 
intravenously (IV). All patients were intubated under direct laryngoscopy 
using cuffed endotracheal tube of appropriate size. 
62 
             Anaesthesia was maintained with Desflurane, initially at 1 MAC 
(minimum alveolar concentration) then titrated to clinical end points with 
Oxygen and N2O at 33:66 ratio. Multimodal anti-emesis consisting of 
Ondansetron 8 mg and Dexamethasone 8 mg intravenously was used. 
GROUP RSB (Rectus Sheath Block)  
         The RSC was inserted bilaterally under ultrasound guidance by the 
anaesthetist immediately following induction of a standard general 
anaesthetic. Under aseptic technique using large sterile drapes with large 
aperture for adequate ultrasound access to abdomen, and under direct 
ultrasound guidance using portable ultrasound machine with a sheathed linear 
transducer probe, Linea alba visualised in the upper abdomen. Probe was then 
moved laterally to visualise the body of the rectus muscle. The posterior 
rectus sheath and the transversalis fascia were clearly visible as a set of 
“tramlines” posterior to the rectus muscle. The ventral rami of the intercostal 
nerves supplying the anterior abdominal wall lie in this potential space 
between the posterior aspect of the rectus muscle and the ‘tramlines’. The 
ultrasound probe was then rotated into a coronal plane.  
       An in-plane approach was used to insert a 16G Tuohy needle and was 
advanced  until the tip lied on top of, or just anterior to the ‘tramlines’ but just 
posterior to the rectus muscle. When the tip of the needle reached the 
posterior sheath (tramlines) the correct position was confirmed by injecting a 
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bolus of normal saline to separate the planes and achieve hydro-dissection. A 
further 20ml of 0.25% bupivacaine was injected down the Tuohy needle and 
that further opened up the potential space between the rectus muscle and 
posterior rectus sheath, allowing the 18 gauge epidural catheters to be 
inserted.  
           The hydro-dissected space and catheters were easily visible on 
ultrasound confirming their correct positioning. The epidural catheter was 
then threaded through the Tuohy needle and about 6-8 cm of catheter was 
inserted into the space and the Tuohy needle was removed. The catheter was 
secured to the skin with adhesive tape. The procedure was repeated on the 
opposite side.  
             Approximately 45 minutes before the end of surgery Inj. Paracetamol 
1000 mg was administered intravenously to provide visceral analgesia. After 
extubation, an intermittent bolus of 20ml of 0.25% bupivacaine   was 
administered every 6 hourly through each rectus sheath catheter. 
              If breakthrough pain was experienced, Inj. Tramadol 100 mg 
intravenous bolus was given and repeated as required for further breakthrough 
pain within the first 48 hours. 
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GROUP TEA--- (THORACIC EPIDURAL ANALGESIA) 
Epidurals were sited prior to the induction of general anaesthesia. 
Standard aseptic insertion technique was followed. The approach used was 
midline. Patient in right lateral position, Epidural space was identified using 
loss of resistance (LOR) to air 18G Tuohy needle was used for identification 
of epidural space. The Tuohy needle is introduced at T10-T11 interspace with 
intermittent compression57 of the syringe plunger attached to the Tuohy 
needle. As the needle is advanced through supraspinous, interspinous 
ligaments and ligamentum flavum there will be a bouncing movement of the 
plunger. As soon as the ligamentum flavum is pierced resistance to syringe 
plunger is lost and epidural space identified at 3 – 5cm from skin level. An 
epidural catheter was threaded into the epidural space via the epidural needle 
and catheter was fixed so that 5 cm of the catheter was in the epidural space. 
Tip of the catheter were placed at T8-T9 level. Following a suitable test dose, 
a bolus of 10 ml 0.125% bupivacaine was administered to establish the block. 
Approximately 45 minutes before the end of surgery Inj.Paracetamol 
1000 mg was administered intravenously. Following extubation, an 
intermittent bolus injection of 0.125% bupivacaine was given epidurally  
6 hourly for 48 hours post operatively.  
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          If breakthrough pain was experienced, then Inj .Tramadol 100 mg 
intravenous bolus was given and repeated as required for further breakthrough 
pain within the first 48 hours. 
OUTCOMES MEASURED 
Primary Outcome measured: 
 Assessment of postoperative pain by Visual Analogue pain score. 
Secondary Outcome measured: 
a. Postoperative Nausea and vomiting 
b. Rescue Analgesic requirement 
c. Patient Satisfaction 
d. Therapeutic /Technical failure rate 
Formats of numerical rating and visual analogue scales. 
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VAS scores: 
 
Figure 20 : VAS Scores 
 
          Visual analogue pain scores were measured on a 0-10 cm scale. VAS 
score of “0” indicates “no pain”, at a score of 4 patient will be uncomfortable 
and at a score of 10 patient will have unbearable pain (fig.17). VAS scores 
were measured at 15, 30, minutes and 2, 4, 8, 16, 24, 30, 36 and 48 hours after 
surgery. When VAS scores are greater than or equal 4, Injection tramadol 100 
mg was given intravenously preceded by Injection Ondansetron 4mg IV. 
Secondary Outcome measures: 
a. Postoperative nausea and vomiting:  
    Patients were assessed for nausea and vomiting by nausea scores 
None 0 
Mild 1 
Moderate 2 
Vomiting 3 
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Rescue anti-emetics were given to patients with nausea score  greater 
than are equal to 2 with Injection Ondansetron 4mg 
b. Patient Satisfaction: 
Patient satisfaction was assessed based on their postoperative analgesia 
at the end of 48 hours. 
Poor 1 
Fair 2 
Good 3 
Excellent 4 
  
c. Therapeutic failure is defined as inadequate pain relief from surgical 
wound and drains. 
d. Technical Failure is the inability to insert TAP catheter/epidural 
catheter as a result of poor tissue planes. 
e. Requirement of rescue analgesia: If the postoperative pain scores as 
measured by visual analogue scale is greater than or equal to 4, then 
rescue analgesia of intravenous tramadol 100mg was given. 
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FLOW CHART OF EVENTS  
1. Written informed consent obtained and patients were explained about 
the procedure  
2. Patient was shifted to premedication room 
3. Monitors connected (NIBP, ECG, Pulse oximeter) 
4. Baseline parameters were noted. 
5. 18G intravenous line was secured. 
6. Ringer Lactate infusion 2ml/kg/hour started 
7. 0.5mg/kg Midazolam and 0.04mg/kg Glycopyrrolate was given 
intramuscularly as premedication 
8. TEA group patients were positioned – Right Lateral position. 
9. Back prepared with Betadine and draped 
10. Epidural space identified by LOR technique and catheter fixed at T8-T9 
level  
     11. Patients in both the group general anaesthesia with endotracheal tube 
using Inj. Fentanyl 2mcg/kg, Inj. Propofol 2mg/kg, Inj. Vecuronium 0.1mg/kg 
was given. 
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     12. After induction patients in RSB group, an ultrasound guided rectus 
sheath catheter was placed bilaterally and 20ml of 0.25% bupivacaine given 
on each side  
     13. Intra op vitals monitored. About 45 min prior to the completion of 
surgical procedure Inj. paracetamol 1000 mg intravenously was given to 
patients in both groups.    
     14. Patients from group RSB were given 20 ml of 0.25% bupivacaine via 
rectus sheath catheter at the end of the procedure and continued as 6 hourly 
intermittent bolus. 
     15. Patients from group TEA received 10 ml of 0.125% bupivacaine via 
epidural catheter at the end of the procedure and continued as 6 hourly 
intermittent bolus.  
     16. Primary outcome measures were numerical rating pain scores/VAS 
scores on a 0-10 cm scale. Scores measured at 15 minutes, 30 minutes, 2 
hours, 4, 8, 16, 24, 30, 36 and 48 hours after surgery.  
    17. Patients were monitored for side effects of the procedure. They were 
monitored for technical / therapeutic failure. 
    18. In case of failure (Technical/Therapeutic), rescue analgesia is with 
injection Tramadol 100 mg through the intravenous route. 
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OBSERVATIONS & RESULTS 
A randomised controlled study was conducted in Govt. Stanley 
Hospital to compare the postoperative analgesic efficacy of Ultrasound 
guided rectus sheath block (RSB) with Thoracic epidural analgesia (TEA) 
following midline laparotomy surgeries. Sample size was calculated to be 100 
patients. The 100 patients were randomly allocated into group RSB and 
Group TEA by draw of lots on the day of surgery. The observation and results 
are as follows. 
  The collected data was analysed with SPSS 16.0 version .To describe 
about the data descriptive statistics frequency analysis, percentage analysis 
were used for categorical variables and the Mean and Standard deviation 
(S.D) were used for continuous variables. To find the significant difference 
between the bivariate samples in independent groups the unpaired sample t-
test was used for normal data and for the skewed data Mann-Whitney U test 
was used. To find the significance in categorical data Chi-Square test was 
used. In all the above statistical tools the probability value less than 0.05 is 
considered as significant level.  
DEMOGRAPHIC PROFILE:-  
 1) AGE: Maximum age in Group RSB was 62 yrs and the minimum 
age was 30 years. Mean age in group RSB was 48.26 years and the standard 
deviation was 7.301 years. In Group TEA, the minimum age was 24 years, 
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whereas the maximum age in Group E was 65 years.  Mean age in Group 
TEA was 46.86 years. These data were computed using student t-test and the 
P value was found to be 0.407. This difference is considered to be not 
statistically significant (Table 2, Figure 21) 
Age in years Group RSB Group TEA P value 
Mean ± SD 48.26±7.301 46.86±9.368 0.407 
Not significant 
 
Table 2 : AGE DISTRIBUTION 
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Figure 21:  AGE DISTRIBUTION 
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2) SEX DISTRIBUTION 
The number of male patients in Group RSB were 42, whereas the 
number of female patients were 8. The number of male patients in Group 
TEA were 37, whereas the female patients were 13 in numbers. The data was 
computed using chi square test. The two tailed P-value equals 0.220, which is 
not statistically significant (Table 3, Figure 22,23). 
SEX Group RSB Group TEA P value 
MALE 42 37 0.220 
Not significant FEMALE 8 13 
 
Table 3: Gender Distribution 
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                                 Figure 22: GENDER DISTRIBUTION 
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Figure 23: GENDER DISTRIBUTION 
 
3)      WEIGHT DISTRIBUTION 
 Maximum weight of the patient in Group RSB was 90 kg, with a 
minimum weight of 56 kg. mean weight in  was 73.20 kg with a standard 
deviation of 9.271 kg, maximum weight of group TEA patients was 90 kg and 
the minimum weight was 55 kg.. Mean weight in Group E was 74.10 kg with 
a standard deviation of 8.742 kg. Data was computed using student t-test.  
The P-value equals 0.619, which is not statistically significant  
(Table 4, Figure 24). 
Weight Group RSB Group TEA P value 
Mean ± SD 73.20±9.271 74.10±8.742 0.619 
Not Significant 
 
Table 4: Weight distribution 
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Figure 24: WEIGHT DISTRIBUTION 
4) ASA PHYSICAL STATUS 
 9 patients in Group RSB and 12 patients in Group TEA had physical 
status of ASA 1. Whereas ASA physical status of 3 was in 11 and 12 patients 
in Group RSB and Group TEA respectively. P value was statistically not 
significant. (Table 5, fig.25) 
ASA Group RSB Group TEA P value 
1 9 12 0.423 
 
Not 
significant 
2 30 26 
3 11 12 
  
                    Table 5: ASA physical status distribution 
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Figure 25: ASA physical status 
 
5) DURATION OF SURGERY: 
 The average duration of surgery in Group RSB was 144.52 minutes 
with a standard deviation of 28.456. The mean duration of surgery in Group 
TEA was 136.70 minutes with a standard deviation of 26.337. The data was 
computed using student t-test. The p value was 0.157 which was not 
statistically significant (table 6, figure 26). 
Duration Group RSB Group TEA P value 
Mean±SD 144.52±28.456 136.70±26.337 0.157 
Not significant 
  
                                      Table 6: Duration of surgery 
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Figure 26: Duration of surgery 
 
6) VAS SCORING: 
TIME GROUP RSB GROUP TEA P value 
15min 3.12±1.769 2.92±1.510 1.000 
30min 3.18±1.976 3.04±1.702 0.788 
2hrs 3.14±1.498 2.80±1.429 0.160 
4hrs 3.06±1.376 2.82±1.240 0.482 
8hrs 3.10±1.389 2.82±0.873 0.571 
16hrs 3.08±1.353 2.92±1.066 0.779 
24hrs 2.76±1.648 2.44±1.163 0.621 
30hrs 2.40±1.294 2.06±0.956 0.153 
36hrs 2.80±0.808 2.58±0.609 0.217 
48hrs 2.18±1.024 2.24±0.797 0.521 
Not Significant 
Table 7: VAS Scores 
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 Postoperative pain scores were measured using visual analogue 
scores in a 0-10cm scale. The visual analogue scores were compared between 
the two groups, Group RSB and Group TEA, VAS scores were measured at 
15minutes, 30 minutes,  2 hours, 4 hours, 8 hours, 16 hours, 24 hours, 30 
hours, 36 hours and 48 hours. The visual analogue scores over the entire 48 
hours were comparable between the two groups. The average VAS scores at 
15 minutes, 30 minutes,  2 hours, 4 hours, 8 hours, 16 hours, 24 hours, 30 
hours, 36 hours and 48 hours for both Group RSB and Group TEA are 
enumerated in table 7 and figure 27. 
 The p-value between the two groups over the entire 48 hours in the 
postoperative period was not statistically significant.(table 7, figure 27) 
 
                                       Figure 27:  VAS SCORING 
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7)  PULSE RATE: 
TIME 
Group RSB 
Mean±SD 
Group TEA 
Mean±SD 
P value Significance 
15min 87.72±11.036 83.12±11.689 0.046 Significant 
30min 86.86±11.920 83.46±11.920 0.157 Not Significant 
2hrs 85.94±9.310 83.56±10.605 0.236 Not Significant 
4hrs 84.08±8.305 82.70±9.416 0.439 Not Significant 
8hrs 84.36±8.420 81.92±7.811 0.136 Not Significant 
16hrs 83.92±8.659 80.56±8.212 0.049 Significant 
24hrs 82.42±7.921 80.84±8.904 0.351 Not Significant 
30hrs 82.60±7.225 79.60±7.902 0.050 Significant 
36hrs 80.92±6.327 78.28±7.088 0.052 Significant 
48hrs 81.16±5.108 78.38±5.566 0.011 Significant 
 
Table 8: PULSE RATE 
 Pulse rate was monitored over a period of 48 hours, in the 
postoperative period in both Group RSB and Group TEA, at intervals of 15 
minutes, 30 minutes, 2 hours, 4 hours, 8 hours, 16 hours, 24 hours, 30 hours, 
36 hours and 48 hours.  
       There was a decrease in pulse rate in Group TEA at all time intervals 
compared to   Group RSB, The p-value was significant at 15 min,16 hours, 
30hours, 36 hours, and 48 hours.(Table 18, figure 28). 
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Figure 28: PULSE RATE 
8)     SYSTOLIC BLOOD PRESSURE: 
TIME 
Group RSB 
Mean±SD 
Group TEA 
Mean±SD 
P value Significance 
15min 126.00±8.281 122.32±10.539 0.055 Significant 
30min 122.08±7.703 113.68±12.655 0.001 Significant 
2hrs 121.46±7.195 115.72±10.637 0.002 Significant 
4hrs 122.32±6.763 118.40±7.091 0.006 Significant 
8hrs 122.94±6.422 118.18±11.215 0.011 Significant 
16hrs 122.50±7.731 118.78±7.547 0.017 Significant 
24hrs 121.46±7.960 119.58±8.320 0.251 Not Significant 
30hrs 122.28±7.326 119.12±8.280 0.046 Significant 
36hrs 120.62±6.827 119.7±6.550 0.493 Not Significant 
48hrs 120.74±6.931 118.08±5.771 0.040 Significant 
Table 9: SYSTOLIC BLOOD PRESSURE 
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            Systolic BP was monitored over a period of 48 hours. There was a 
significant fall in systolic BP over the entire 48 hours in Group TEA except at 
24 and 36 hours as depicted in Table 9 and figure 29. The p-value was found 
to be statistically significantly at all time intervals. 
 
Figure 29: SYSTOLIC BLOOD PRESSURE 
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9)  DIASTOLIC BLOOD PRESURE: 
TIME 
Group RSB 
Mean±SD 
Group TEA 
Mean±SD 
P value Significance 
15min 74.63±6.85 68.53±3.709 0.664 Not Significant 
30min 75.3±7.87 68.76±4.57 0.174 Not Significant 
2hrs 75.15±7.47 70±5.52 0.391 Not Significant 
4hrs 74±6.74 70.86±3.342 0.610 Not Significant 
8hrs 74±6.08 70.86±3.85 0.193 Not Significant 
16hrs 74.3±7.00 70.9±3.462 0.336 Not Significant 
24hrs 73.16±5.88 71.1±3.94 0.598 Not Significant 
30hrs 72.93±5.28 71.08±3.919 0.348 Not Significant 
36hrs 73.26±6.06 71.36±3.53 0.785 Not Significant 
48hrs 73.65±6.334 71.31±3.74 0.584 Not Significant 
 
Table 10: DIASTOLIC BLOOD PRESURE 
 
 Diastolic BP was measured over the 48 hours postoperative period, at 
specified time intervals. The mean diastolic blood pressure was found to be 
lower in Group TEA than Group RSB at all time intervals as depicted in 
Table 10 /figure 30. But the P value was found to be statistically not 
significant at all time intervals. 
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                    Figure 30: DIASTOLIC BLOOD PRESSURE 
10)  MEAN ARTERIAL PRESURE: 
TIME GROUP RSB 
mean±SD 
GROUP TEA 
mean±SD 
P value Significance 
15min 92.29±5.48 91.43±6.07 0.455 Not Significant 
30min 89.80±6.19 85.61±8.05 0.004 Significant 
2hrs 89.27±5.35 86.56±7.30 0.037 Significant 
4hrs 89.32±5.17 87.63±4.35 0.080 Not Significant 
8hrs 89.66±4.92 87.13±5.32 0.015 Significant 
16hrs 89.74±5.42 87.74±4.65 0.050 Significant 
24hrs 88.94±4.63 87.94±3.59 0.270 Not Significant 
30hrs 89.17±4.10 87.51±4.23 0.048 Significant 
36hrs 88.70±4.76 88.21±4.07 0.579 Not Significant 
48hrs 88.91±4.80 87.91±3.92 0.580 Not Significant 
 
Table 11: MEAN ARTERIAL PRESSURE 
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MAP was measured over the entire 48 hours postoperative period, at 
specified time intervals. The mean arterial pressure was found to be lower in 
Group TEA than Group RSB at all time intervals as depicted in Table 11/ 
figure 31. The P – value was found to be statistically significant, at 30 min, 2 
hours, 8 hours, 16 hours and at 30 hours. 
 
Figure 31: MEAN ARTERIAL PRESSURE 
11)  POST OPERATIVE NAUSEA : 
              Postoperative nausea and vomiting scores were measured over the 
48hours. The scores were: No nausea = 0, mild nausea = 1, moderate nausea = 
2, vomiting = 3. Rescue antiemetic was given if nausea score  2. Nausea 
score of 2 was in 13 patients in group RSB and vomiting was present in 3 
patients. Nausea score of 2 was in 11 patients in Group TEA and 6 patients 
had vomiting . (Table 12, figure 32). P value was found to be not significant. 
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PONV SCORE Group RSB Group TEA P value 
0 18 22 0.477 
Not Significant 1 16 11 
2 13 11 
3 3 6 
 
Table 12: POST OPERATIVE NAUSEA AND VOMITING 
 
 
Figure 32: PONV SCORE 
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12) OVERALL PATIENT SATISFACTION 
 Postoperative satisfaction scores were poor = 1, fair = 2, Good = 3 
and excellent = 4. In group RSB, 8 patients recorded score 1 and 22 patients 
scored 4. In Group TEA, 7 patients recorded scored 1 and 26 patients 
recorded score of 4 (Table 13, figure 33). P value was statistically 
insignificant. 
 Group RSB Group TEA P value 
1 8 7 0.875 
Not significant 2 3 3 
3 17 14 
4 22 26 
 
Table 13: PATIENT SATISFACTION 
 
Figure 33: PATIENT SATISFACTION 
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13)  FAILURE RATE 
  In group RSB patients, therapeutic failure rate was found in 8 out of 
50 patients. In Group TEA therapeutic failure rate was found in 6 out of 50 
patients. P value was found to be statistically insignificant. (Table 14, figure 
34). 
 GROUP RSB GROUP TEA P value 
NO 42 44 0.564 
Not Significant YES 8 6 
  
                                        Table 14: FAILURE RATE 
 
 
Figure 34: THERAPEUTIC FAILURE RATE 
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14)  RESCUE ANALGESIC REQUIREMENT 
  Rescue analgesics were provided when Visual Analogue Score (VAS) 
scores  4, or on patient demand. Out of 50 patients in Group RSB, 13 of 
them required rescue analgesics, and in Group TEA also 11 patients required 
rescue analgesics. P value was found to be statistically insignificant. (Table 
15, figure 35). 
 GROUP RSB GROUP TEA P value 
NO 37 39 0.640  
Not significant YES 13 11 
 
Table 15: RESCUE ANALGESIC REQUIREMENT 
 
                    
Figure 35: RESCUE ANALGESIC REQUIREMENT 
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15) HYPOTENSION 
In Group RSB, there was no incidence of hypotension in all 50 
patients. Whereas in Group TEA, there was significant hypotension in 10 out 
of 50 patients. The P value was 0.001, which is statistically significant (table 
16, figure 36). 
 Group RSB Group TEA P value 
NO 50 40 0.001 
Significant YES 0 10 
  
Table 16: HYPOTENSION 
 
 
Figure 36: HYPOTENSION 
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16)    BRADYCARDIA 
No patient in either group had bradycardia at any point of time during the 
study (Table 17, fig 37). 
 Group RSB Group TEA 
YES 0 0 
NO 50 50 
  
                                           Table 17: BRADYCARDIA 
          
                                         Figure 37: BRADYCARDIA 
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DISCUSSION 
Midline laparotomy is performed commonly as elective or emergency 
surgery. Pain associated with these surgeries have considerable pain 
postoperatively which needs to be addressed. A good postoperative analgesic 
regimen is important to alleviate stress response in the postoperative period to 
improve the postoperative outcomes. Adequate postoperative analgesia 
facilitates earlier patient mobilisation and accelerates recovery. 
Pain after laparotomy is more noticeable in the first two postoperative 
days. The pain is aggravated during mobilisation or coughing. Patients 
undergoing laparotomy are usually managed with intravenous opioids for 
postoperative analgesia. But systemic opioids provide analgesia when patient 
is at rest. Analgesia even on movement or coughing is provided essentially by 
regional anaesthesia techniques in the postoperative period. The gold standard 
technique that has been used for postoperative pain relief is epidural 
analgesia. With the advent of ultra-sonogram, truncal nerve blocks are gaining 
popularity. One of the most promising USG guided truncal nerve blocks used 
for postoperative pain relief in laparotomy is the rectus sheath block (RSB). 
While there are various studies comparing epidural analgesia with 
conventional intravenous opioids and USG guided RSB with systemic opioids 
for post-operative pain relief, there are only very few studies comparing 
epidural analgesia with USG guided rectus sheath block. 
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We conducted this randomized prospective observer blinded clinical 
study to compare the analgesic efficacy of USG guided rectus sheath  with 
thoracic epidural analgesia for post-operative pain relief in patients 
undergoing midline laparotomy surgery under general anaesthesia. In this 
study we planned to test the hypothesis that USG guided rectus sheath block 
would provide optimal post-operative analgesia that will be comparable to 
epidural analgesia.  
           So we conducted a study comparing the pain scores between rectus 
sheath block (RSB) group and thoracic epidural analgesia (TEA) group over a 
period of 48 hours. In addition post-operative nausea and vomiting (PONV), 
patient satisfaction at 48 hours, rescue analgesia with injection tramadol, 
complications associated with the procedure were evaluated between the 2 
groups. The hemodynamic parameter over a period of 48 hours was also 
compared between RSB group and TEA group. Study was an observer 
blinded randomised clinical trial. Sample size selected was 100.  
 As far as the inclusion criteria was concerned, patients between the 
ages of 18-65 years were selected, since extremes of age will be a 
confounding variable. As far as ASA physical status concerned, ASA-PS, 
ASA-PS II and ASA-PS III patients were included in the study. 
 Patients who were excluded from the study were, patients with known 
hypersensitivity to local anaesthetics, patients with abnormal coagulation 
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status, pregnancy and patients with severe systemic illness Since Group TEA 
patients received epidural analgesia, patients with abnormal coagulation status 
and those with skin lesion at the site of blockade were excluded from the 
study. 
            Patients from both the groups were analysed for the demographic 
profile. Patients mean age and standard deviation were comparable between 
the RSB group and TEA group. Sex distribution were also comparable. The 
mean weight were similar between the two groups and the p-value computed 
using student t-test was insignificant. So the demographic profile as computed 
by student t-test and Chi-square test were similar between the RSB group and 
the TEA group. 
 In Group TEA the epidural catheter was placed before the induction of 
general anaesthesia. 16G Tuohy needle was used to identify epidural space 
with loss of resistance technique, using midline approach. In Group RSB the 
rectus sheath catheters were placed after the induction of general anaesthesia 
and before the surgical incision. USG guided rectus sheath block was 
performed using high frequency, linear array USG probe (6-12MHz). The 
Linear array probe was positioned transversely to identify the rectus muscle, 
then probe was moved laterally. Then using USG guidance a 16G Tuohy 
needle was inserted in an in-plane technique to locate the plane between the 
rectus muscle and the posterior rectus sheath.16G Tuohy needle was clearly 
distinct under real time USG. One factor which undoubtedly defines the 
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success rate of the block was clear visualisation of the needle tip at all time 
during the block. 
 Real time visualisation of the expansion of rectus sheath plane, was 
done by injecting via the Tuohy needle 4-5ml of normal saline. This is 
defined as the hydro-dissection of the plane between the posterior border of 
rectus muscle and posterior rectus sheath 
 Optimal needle location is indicated by the appearance of an 
“anechoic” fluid collection. Then the epidural catheter is inserted 4-6cm 
beyond the needle tip into the rectus plane. 20 ml of 0.25% Inj. bupivacaine 
via rectus sheath catheter was given and continued as intermittent bolus every 
6 hours. 
             The local anaesthetic that was used in both the groups was 
bupivacaine. Bupivacaine is a commonly used drug both in epidural analgesia 
as well as USG guided rectus sheath block. In our study Bupivacaine was 
given as intermittent boluses in both RSB and TEA groups every 6 hours over 
a period of 48 hours postoperatively. 
20 ml of injection 0.25 % bupivacaine was used in each rectus sheath 
catheters in RSB group patients and was repeated every 6 hours. 10 ml of 
injection 0.125% bupivacaine was used in TEA group and was repeated every 
8 hours. 
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          The primary outcome measure that was compared between the RSB 
group and TEA group, was the pain scores graded by visual analogue scores. 
The VAS scores were graded on a 0-10 cm scale. VAS scores were observed 
over a period of 48 hours in the postoperative period. VAS scores were 
observed at 15 minutes, 30 minutes, 2 hours, 4 hours, 8 hours, 16 hours, 24 
hours, 30 hours, 36 hours and 48 hours. 
 The mean VAS scores at all the time intervals, measured were 
comparable between the RSB group and the TEA group. The p-value 
computed was statistically not significant. So the analgesic efficacy of USG 
guided RSB as measured by visual analogue pain scores were comparable 
with thoracic epidural analgesia. 
  One of the secondary outcome measures that were analysed was 
postoperative nausea and vomiting (PONV). Rescue anti-emetic, Inj. 
Ondensetron 4 mg intravenously was given when the PONV scores were  2. 
Average PONV scores were similar in both the groups. Incidence of vomiting 
would have been higher if an epidural narcotics were used as additive. 
However in our study 0.125% bupivacaine was alone used for epidural 
analgesia as intermittent boluses every 8 hours. 
 The next outcome measured was postoperative satisfaction score. A 
score of 4 which meant excellent postoperative satisfaction was recorded in 
22 patients in Group RSB compared to 26 patients in group TEA. The mean 
postoperative satisfaction was slightly better in the Epidural group. This may 
be because of the vague underlying dull visceral pain in the RSB group. 
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Rescue analgesia was given as per the patient requirement and on 
patients demand. Rescue analgesia was given if VAS scores were greater than 
or equal to 4. Injection ondansetron 4 mg was given before administering 
Inj.Tramadol 100 mg. Rescue analgesia was required in 13 of the 60 patients 
in the RSB group and 11 of the 50 patients in the TEA group. So requirement 
of rescue analgesia was comparable in both the groups. 
There was no incidence of bradycardia, respiratory depression, urinary 
retention in both the groups, but there was significant hypotension in the 
epidural group. 10 out of the 50 patients had hypotension that is defined as 
mean arterial pressure < 20% from baseline values. Episodes of hypotension 
were treated with fluid boluses of normal saline or ringer lactate. Patients who 
do not respond to crystalloids were to be given injection ephedrine. But all 
patients responded to fluid boluses. Physiological effect of sympathetic 
blockade was the reason behind this hypotension in TEA group. But there was 
no incidence of hypotension reported in the RSB group.  
As far as the hemodynamic parameters are concerned there was a 
significant fall in systolic blood pressure and mean arterial pressure at 
periodic time intervals after activation of epidural catheter. So we concluded 
that USG guided TAP block was comparable to epidural analgesia in terms of 
post-operative pain relief. However in the epidural group incidence of 
hypotension was significant. 
Adverse effects of epidural analgesia include unintentional dural 
puncture, transient neuropathy, spinal hematoma, CNS infections moreover 
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intrathecal or intravascular catheter migration can lead on to disastrous 
complications. Hypotension is present in epidural anaesthesia due to 
sympathetic blockade. Lower limb motor block is uncommon when using low 
concentrations of bupivacaine but when present can restrict early ambulation 
of the patient. Urinary retention is seen when sacral segments S2 to S4 are 
blocked by epidural analgesia. 
         Advantages of this USG guided RSB include optimal analgesia without 
the significant risk associated with neuraxial blocks especially when patients 
are on drugs which affect the coagulation such as aspirin, clopidogrel, heparin 
and others. Also in the setting of sepsis RSB can be judiciously used with 
minimal risk whereas epidural is contraindicated in such situations. Unlike in 
epidural, during insertion of the rectus sheath catheters, patient need not be 
accurately positioned and the procedure can be done after the induction of 
general anaesthesia which avoids the patients’ discomfort. RSB has no 
significant haemodynamic effects which allows this technique to be used 
safely in patients presenting with hypotension either due to hypovolemia or 
sepsis in emergency situations.  
     Adding adjuvants to the local anaesthetic in RSB would further enhance 
the efficacy and duration of the block 
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CONCLUSION 
The randomised controlled study conducted to compare the analgesic 
efficacy of Ultrasound guided rectus sheath block with thoracic epidural 
analgesia for postoperative pain relief in midline laparotomy surgeries 
concluded that ultrasound guided RSB is comparable to epidural analgesia. 
USG guided RSB can be an effective alternative and is easier to learn and less 
invasive technique compared to epidural analgesia, USG guided RSB would 
play an important  part of the postoperative analgesia regimen, devoid of the 
side effects of epidural anaesthesia. 
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PROFORMA 
 
Name:                                                          Wt: 
Age/sex:       Male/Female                                                               
Date:                                                                  
IP No:                                                         ASA: 
Diagnosis:                                                  COMORBID CONDITIONS: 
Procedure: 
Group Allocated:                     RSB/TEA 
Time of start of surgery: 
 
Epidural Level 
 
STANDARD GENERAL ANAESTHESIA 
Premedication Inj.glycopyrrolate 
Inj.midazolam 
Preoxygenation 100% O2 for 3 min @6L/min 
Induction Inj.fentanyl 
Inj.propofol 
Inj.vecuronium 
Intubation  
Maintenance N20:O2 
Volatile agent  
 
Reversal: Inj. Neostigmine                                                                                                                                                                                                                           
Inj.glycopyrrolate 
 EXTUBATED: YES/NO                              TIME: 
TOTAL DURATION OF SURGERY: 
POST OPERATIVE MONITORING 
INTERMITTENT BOLUS (6 hourly) INJ.BUPIVACAINE 
 1 2 3 4 5 6 7 8 
RSB(0.25% --20ml 
in each catheter) 
        
TEA 0.125%---10ml         
 
POSTOP MONITORING 
TIME VAS PR BP MAP SPO2 
15 min      
30 min      
2 hr      
4 hr      
8 hr      
16 hr      
24 hr      
30 hr      
36 hr      
48 hr      
 
SECONDARY OUTCOMES 
PONV 0 1 2 3  
RESCUE ANALGESIA YES NO    
PATIENT SATISFACTION 1 
poor 
2 
fair 
3 
good 
4 
excellent 
 
TECHNICAL/THERAPEUTIC 
FAILURE 
YES NO    
 
COMPLICATIONS 
HYPOTENSION YES NO 
BRADYCARDIA YES NO 
RESP.DEPRESSION YES NO 
OTHERS (If any)   
MASTER CHART 
DATE S. NO GROUP NAME AGE SEX WEIGHT IP NO DURATION DIAGNOSIS PROCEDURE 
04-05-15 1 RSB ASHOKAN 44 M 64 1532119 140 SUBACUTE INTESTINAL OBSTUCTION LAPAROTOMY 
06-05-15 2 RSB SUNDARAMOORTHY 52 M 75 1532176 125 CA STOMACH LAPAROTOMY 
08-05-15 3 TEA FAILABATH 48 F 66 1532342 130 OBSTRUCTED INCISIONAL HERNIA LAPAROTOMY 
08-05-15 4 TEA THILAGAVATHY 38 F 56 1536431 160 INCISIONAL HERNIA MESH REPAIR 
09-05-15 5 RSB MUTHIAYAN 35 M 82 1534287 120 POST ILEOSTOMY STATUS ILEOSTOMY CLOSURE 
10-05-15 6 TEA VISHWANATHAN 44 M 72 1533274 100 APPENDICULAR PERFORATION LAPAROTOMY 
11-05-15 7 RSB MUTHU 53 M 66 1533795 135 CHOLEDOCHOLITHIASIS CBD EXPLORATION 
13-05-15 8 RSB KANNIAPPAN 49 M 60 1533532 128 CA STOMACH LAPAROTOMY 
15-05-15 9 RSB SHANMUGAM 30 M 78 1533268 185 UMBILICAL HERNIA MESH REPAIR 
15-05-15 10 TEA SIVAKUMAR 46 M 87 1533843 125 OBSTRUCTED INCISIONAL HERNIA ANATOMICAL REPAIR 
17-05-15 11 RSB NIRMALA 58 F 64 1533921 145 SUBACUTE INTESTINAL OBSTUCTION LAPAROTOMY 
17-05-15 12 RSB GOPAL 55 M 77 1533970 138 CA STOMACH LAPAROTOMY 
18-05-15 13 TEA SUNDARAM 54 M 75 1533654 120 INCISIONAL HERNIA MESH REPAIR 
20-05-15 14 TEA RAJAKUMAR 38 M 64 1534012 125 APPENDICULAR PERFORATION LAPAROTOMY 
23-05-15 15 RSB GANESAN 60 M 88 1533874 150 APPENDICULAR PERFORATION LAPAROTOMY 
24-05-15 16 TEA DHANASEKAR 45 M 86 1533901 125  L OVARIAN CYST LAPAROTOMY 
24-05-15 17 TEA DEVI 39 F 78 1534276 140 CHOLEDOCHOLITHIASIS CBD EXPLORATION 
29-05-15 18 RSB SAMPATH 48 M 78 1534326 120 INTESTINAL OBSTRUCTION LAPAROTOMY 
29-05-15 19 RSB MURUGAN 49 M 76 1534322 125 DU PERFORATION LAPAROTOMY 
31-05-15 20 TEA SRINIVASAN 42 M 56 1534375 160 SUBACUTE INTESTINAL OBSTUCTION LAPAROTOMY 
01-06-15 21 TEA PERUMAL 38 M 82 1534432 120 APPENDICULAR PERFORATION LAPAROTOMY 
02-06-15 22 RSB MOHAMMED ALI 51 M 77 1534197 115 CA STOMACH LAPAROTOMY 
02-06-15 23 RSB MANIKARAJ 48 M 75 1534498 120 APPENDICULAR PERFORATION LAPAROTOMY 
02-06-15 24 TEA PRABHU 29 M 86 1534742 135 CA HEAD OF PANCREAS TRIPLE BYPASS 
04-06-15 25 TEA VENKATESAN 57 M 78 1534532 165 OBSTRUCTED INCISIONAL HERNIA LAPAROTOMY 
05-06-15 26 TEA MURUGAN 43 M 86 1534254 150 INCISIONAL HERNIA MESH REPAIR 
07-06-15 27 RSB MARIAMMAL 40 F 58 1535434 120 POST LAP.CHOLECYSTECTOMY STATUS LAPAROTOMY 
04-07-15 28 TEA KARTHI 24 M 78 1537653 130 OBSTRUCTED INCISIONAL HERNIA LAPAROTOMY 
08-07-15 29 RSB DHANUSH 36 M 64 1538690 140 INTESTINAL OBSTRUCTION LAPAROTOMY 
08-07-15 30 RSB VASANTHA 50 F 87 1538551 135 INTESTINAL OBSTRUCTION LAPAROTOMY 
DATE S. 
NO 
GROUP NAME AGE SEX WEIGHT IP NO DURATION DIAGNOSIS PROCEDURE 
08-07-15 31 TEA IRUDHAYASAMY 50 M 65 1539207 122 HOLLOW VISCOUS PERFORATION LAPAROTOMY 
08-07-15 32 RSB ASHOK 44 M 75 1536375 180 HEPATIC FLEXURE GROWTH R HEMICOLECTOMY 
08-07-15 33 RSB RAMESH 49 M 66 1536506 125 LOOP ILEOSTOMY ILEOSTOMY TAKE DOWN 
08-07-15 34 TEA BHASKAR 38 M 75 1536595 130 LOOP ILEOSTOMY ILEOSTOMY TAKE DOWN 
09-07-15 35 RSB MOHAN 43 M 76 1525983 190 CHOLELITHIASIS WITH CHOLEDOCOLITHIASIS CHOLECYSTECTOMY  
10-07-15 36 TEA SUDHA 43 F 87 1531930 190 CA ASCENDING COLON R HEMICOLECTOMY 
13-07-15 37 TEA RAJA 50 M 66 1539562 145 SMALL BOWEL PERFORATION LAPAROTOMY 
14-07-15 38 RSB BABU 45 M 56 1535586 115 LOOP COLOSTOMY STATUS COLOSTOMY CLOSURE 
14-07-15 39 RSB PONVEL 42 M 64 1536254 180 PSEUDOCYST OF PANCREAS CYSTOGASROSTOMY 
15-07-15 40 TEA PUSHPA 29 F 55 1538935 105 UMBILICAL HERNIA ANATOMICAL REPAIR 
15-07-15 41 TEA PUNITHA 35 F 58 1539811 125 SUBACUTE INTESTINAL OBSTUCTION LAPAROTOMY 
15-07-15 42 RSB ANNAMALAI 56 M 76 1539823 150 DU PERFORATION LAPAROTOMY 
17-07-15 43 RSB NEELAKANDAN 60 M 65 1540446 165 SUBACUTE INTESTINAL OBSTUCTION LAPAROTOMY 
20-07-15 44 TEA VARADHARAJAN 65 M 66 1540535 180 SUBACUTE INTESTINAL OBSTUCTION LAPAROTOMY 
21-07-15 45 RSB RAMESH 37 M 75 1538402 190 CA STOMACH LAPAROTOMY 
29-07-15 46 RSB RAJESHWARI 51 F 58 1537348 260 PERIAMPULLARY CA WHIPPLES PROCEDURE 
01-08-15 47 TEA MALLIGA 50 F 66 1538743 185 CA      R    OVARY TAH  
04-08-15 48 TEA SUBBURAYAN 47 M 66 1538888 245 RETROPERITONEAL SARCOMA LAPAROTOMY 
04-08-15 49 RSB RAVICHANDRAN 57 M 76 1541792 155 CHOLEDOCHOLITHIASIS CBD EXPLORATION 
11-08-15 50 TEA RAJENDRAN  56 M 76 1543692 165 CHOLEDOCHOLITHIASIS CBD EXPLORATION 
14-08-2015 51 RSB DHANUSHAN 62 M 75 1538690 195 CA DESCENDING COLON L HEMICOLECTOMY 
14-08-2015 52 TEA YUVARAJ 44 M 86 1539287 120 APPENDICULAR PERFORATION LAPAROTOMY 
15-08-2015 53 RSB SATHISH 37 M 76 1540128 145 INCISIONAL HERNIA MESH REPAIR 
17-08-2015 54 TEA PADMAVATHY 49 F 77 1540234 115 UMBILICAL HERNIA ANATOMICAL REPAIR 
18-08-2015 55 TEA MUTHUKRISHNAN 55 M 75 1540225 120 INCISIONAL HERNIA MESH REPAIR 
18-08-2015 56 TEA SRINIVASAN 58 M 78 1540119 135 INTESTINAL OBSTRUCTION LAPAROTOMY 
19-08-2015 57 RSB RAFIQ 44 M 86 1540365 120 SUBACUTE INTESTINAL OBSTUCTION LAPAROTOMY 
22-08-2015 58 TEA MURUGESAN 58 M 90 1540748 100 CA STOMACH LAPAROTOMY 
22-08-2015 59 TEA KRISHNAN 47 M 76 1540634 125 CHOLEDOCHOLITHIASIS CBD EXPLORATION 
23-08-2015 60 TEA RAJESH 47 M 74 1540923 130 UMBILICAL HERNIA ANATOMICAL REPAIR 
23-08-2015 61 RSB THANGAM 53 F 73 1540819 180 APPENDICULAR ABCESS LAPAROTOMY 
23-08-2015 62 TEA LAKSHMIPATHY 48 M 75 1540229 125 HOLLOW VISCOUS PERFORATION LAPAROTOMY 
24-08-2015 63 RSB RAMANUJAM 42 M 86 1540912 130 INCISIONAL HERNIA LAPAROTOMY 
25-08-2015 64 RSB AMARDAS 44 M 69 1541003 150 OBSTRUCTED INCISIONAL HERNIA MESH REPAIR 
25-08-2015 65 RSB NAGAPPAN 51 M 63 1540843 135 UMBILICAL HERNIA MESH REPAIR 
26-08-2015 66 TEA SINGAN 60 M 75 1540834 120 SUBACUTE INTESTINAL OBSTUCTION LAPAROTOMY 
DATE S. 
NO 
GROUP NAME AGE SEX WEIGHT IP NO DURATION DIAGNOSIS PROCEDURE 
27-08-2015 67 TEA DHARMALINGAM 54 M 85 1540913 160 UMBILICAL HERNIA MESH REPAIR 
28-08-2015 68 RSB ANANDHI 38 F 78 1540919 145 APPENDICULAR PERFORATION LAPAROTOMY 
28-08-2015 69 RSB GANESAN 51 M 56 1541237 120 POST ILEOSTOMY STATUS ILEOSTOMY CLOSURE 
28-08-2015 70 TEA GOPI 55 M 69 1541288 120 UMBILICAL HERNIA MESH REPAIR 
30-08-2015 71 TEA PARVATHY 40 F 75 1540975 118 CA STOMACH LAPAROTOMY 
30-08-2015 72 RSB KESAVAN 48 M 78 1540899 145 INCISIONAL HERNIA MESH REPAIR 
31-08-2015 73 RSB SAMPATH 55 M 59 1541020 185 CHOLEDOCHOLITHIASIS CBD EXPLORATION 
31-08-2015 74 TEA KARTHIGA 29 F 78 1541176 125 SUBACUTE INTESTINAL OBSTUCTION LAPAROTOMY 
31-08-2015 75 RSB JANAKIRAMAN 52 M 77 1541213 140 UMBILICAL HERNIA MESH REPAIR 
01-09-2015 76 TEA KARUNAKARAN 57 M 74 1541294 130 SUBACUTE INTESTINAL OBSTUCTION LAPAROTOMY 
01-09-2015 77 RSB VENKATESAN 42 M 82 1541229 120 CA STOMACH LAPAROTOMY 
01-09-2015 78 RSB GNANAVEL 49 M 90 1542034 115 UMBILICAL HERNIA MESH REPAIR 
02-09-2015 79 RSB SOMASUNDARAM 59 M 59 1541789 155 SUBACUTE INTESTINAL OBSTUCTION LAPAROTOMY 
02-09-2015 80 TEA CHIDAMBARAM 55 M 75 1541984 140 APPENDICULAR PERFORATION LAPAROTOMY 
03-09-2015 81 TEA KESAVAN 40 M 77 1541993 130 LIVER ABCESS LAPAROTOMY 
04-09-2015 82 TEA PUSHPARAJ 48 M 76 1542164 145 CHOLEDOCHOLITHIASIS CBD EXPLORATION 
04-09-2015 83 RSB RAJAMMAL 55 F 68 1542266 120 UMBILICAL HERNIA MESH REPAIR 
04-09-2015 84 TEA VASANTHAKUMAR 58 M 68 1541843 120 APPENDICULAR ABCESS LAPAROTOMY 
05-09-2015 85 RSB SIMSON 38 M 78 1541854 130 UMBILICAL HERNIA MESH REPAIR 
05-09-2015 86 TEA PARTHASARATHY 40 M 66 1541972 145 INTESTINAL OBSTRUCTION LAPAROTOMY 
05-09-2015 87 RSB SENTHIL 48 M 87 1542167 160 SUBACUTE INTESTINAL OBSTUCTION LAPAROTOMY 
06-09-2015 88 RSB RAJADURAI 52 M 81 1542286 135 PARA UMBILICAL HERNIA MESH REPAIR 
06-09-2015 89 TEA SUGANTHI 49 F 88 1542212 130 INCISIONAL HERNIA MESH REPAIR 
06-09-2015 90 RSB MANIKANDAN 53 M 73 1542200 120 APPENDICULAR PERFORATION LAPAROTOMY 
07-09-2015 91 TEA THULASI 55 F 74 1542198 120 OBSTRUCTED INCISIONAL HERNIA LAPAROTOMY 
07-09-2015 92 TEA BALAKRISHNAN 40 M 68 1542197 110 CA STOMACH LAPAROTOMY 
08-09-2015 93 RSB VIJAYAN 44 M 68 1544276 125 BLUNT INJURY ABDOMEN LAPAROTOMY 
08-09-2015 94 RSB KASTHURI 57 F 73 1544154 140 INCISIONAL HERNIA MESH REPAIR 
08-09-2015 95 TEA CHOKKAMMA 50 F 64 1543298 135 INCISIONAL HERNIA MESH REPAIR 
09-09-2015 96 RSB JAYACHANDRAN 47 M 84 1543207 115 APPENDICULAR PERFORATION LAPAROTOMY 
10-09-2015 97 TEA MANI 59 M 77 1544265 120 INTESTINAL OBSTRUCTION LAPAROTOMY 
10-09-2015 98 TEA MOHAN 54 M 75 1544209 135 UMBILICAL HERNIA MESH REPAIR 
10-09-2015 99 RSB PERIYASAMY 50 M 85 1544215 150 CHOLEDOCHOLITHIASIS CBD EXPLORATION 
10-09-2015 100 TEA KUPPAN 56 M 80 1544302 185 CA STOMACH LAPAROTOMY 
 
 S.NO Group PS 
VAS 
PONV        
Score 
Patient             
satisfac  -
tion 
TechnicaL      
Failure Rescue          Analgesia 
Brady -
cardia 
Hypo- 
Tension 
Respiratory            
Depression 15 30 2 4 8 16 24 30 36 48 
1 RSB 2 2 2 3 3 2 2 3 2 2 1 3 4 NO NO NO NO NIL 
2 RSB 3 2 2 2 3 3 2 2 2 2 1 3 4 NO NO NO NO NIL 
3 TEA 2 3 4 4 3 3 3 4 2 2 2 1 2 NO YES NO NO NIL 
4 TEA 1 3 2 2 3 3 2 2 2 3 2 1 3 NO NO NO YES NIL 
5 RSB 2 2 2 3 2 3 3 2 2 3 1 0 4 NO NO NO NO NIL 
6 TEA 2 2 3 3 2 2 2 2 2 2 2 0 4 NO NO NO NO NIL 
7 RSB 1 3 2 2 3 2 2 2 2 2 2 0 4 NO NO NO NO NIL 
8 RSB 3 7 6 5 5 7 7 5 4 4 4 2 1 YES YES NO NO NIL 
9 RSB 1 2 2 3 2 3 3 2 2 3 1 0 3 NO NO NO NO NIL 
10 TEA 2 3 4 6 4 4 3 3 2 2 2 3 2 YES YES NO NO NIL 
11 RSB 1 2 2 2 2 2 3 2 1 2 2 1 4 NO NO NO NO NIL 
12 RSB 3 3 3 3 1 3 3 2 2 3 1 0 4 NO NO NO NO NIL 
13 TEA 2 2 2 1 3 2 2 2 1 3 2 0 4 NO NO NO NO NIL 
14 TEA 2 2 2 2 1 2 2 2 2 2 2 2 3 NO NO NO YES NIL 
15 RSB 2 2 2 2 2 2 3 2 2 2 2 0 4 NO NO NO NO NIL 
16 TEA 3 3 3 3 3 3 3 3 3 2 1 0 4 NO NO NO NO NIL 
17 TEA 3 2 2 2 2 2 3 2 1 3 3 1 3 NO NO NO YES NIL 
18 RSB 1 4 8 6 4 4 7 7 5 4 3 3 1 YES YES NO NO NIL 
19 RSB 2 2 2 2 1 2 2 2 2 2 2 2 3 NO NO NO NO NIL 
20 TEA 2 2 1 3 3 3 3 2 2 3 1 1 4 NO NO NO NO NIL 
21 TEA 1 3 3 1 2 3 2 1 1 2 3 1 3 NO NO NO NO NIL 
22 RSB 2 2 3 3 3 2 3 2 2 3 3 1 3 NO NO NO NO NIL 
23 RSB 1 2 1 3 3 3 3 2 2 3 1 0 3 NO NO NO NO NIL 
24 TEA 2 3 1 2 1 2 3 2 2 3 2 1 4 NO NO NO NO NIL 
25 TEA 2 3 3 1 2 3 2 1 1 2 3 2 4 NO NO NO NO NIL 
26 TEA 1 3 1 2 1 2 3 2 2 3 2 0 3 NO NO NO NO NIL 
27 RSB 1 3 2 3 3 2 2 2 3 3 2 2 3 NO NO NO NO NIL 
28 TEA 2 2 2 1 2 3 2 1 1 3 1 0 4 NO NO NO NO NIL 
S.NO Group PS 
VAS 
PONV        
Score 
Patient             
satisfac  -
tion 
TechnicaL      
Failure Rescue          Analgesia 
Brady -
cardia 
Hypo- 
Tension 
Respiratory            
Depression 15 30 2 4 8 16 24 30 36 48 
29 RSB 2 3 3 3 5 5 4 4 2 2 2 0 2 NO YES NO NO NIL 
30 RSB 2 5 7 5 6 4 4 7 4 3 3 2 1 YES YES NO NO NIL 
31 TEA 3 2 2 1 2 3 2 1 1 3 1 0 4 NO NO NO NO NIL 
32 RSB 3 2 3 3 3 3 3 2 2 3 3 1 4 NO NO NO NO NIL 
33 RSB 2 3 3 3 3 2 2 3 2 2 2 2 3 NO NO NO NO NIL 
34 TEA 2 2 3 3 3 3 3 2 2 3 3 0 3 NO NO NO YES NIL 
35 RSB 2 2 3 3 3 2 3 2 2 3 3 1 3 NO NO NO NO NIL 
36 TEA 3 2 3 3 3 3 3 2 2 3 3 0 4 NO NO NO NO NIL 
37 TEA 3 3 3 3 3 3 3 3 2 2 2 1 3 NO NO NO NO NIL 
38 RSB 2 6 8 5 4 7 3 3 3 3 3 2 1 YES YES NO NO NIL 
39 RSB 2 2 2 1 2 3 2 1 1 3 1 0 4 NO NO NO NO NIL 
40 TEA 1 2 3 3 3 2 3 2 2 3 3 0 4 NO NO NO NO NIL 
41 TEA 1 8 8 5 4 4 5 5 4 4 4 0 1 YES YES NO YES NIL 
42 RSB 3 2 2 1 2 3 2 1 1 3 1 0 3 NO NO NO NO NIL 
43 RSB 1 2 3 3 3 2 3 2 2 3 3 1 3 NO NO NO NO NIL 
44 TEA 2 5 8 5 7 4 6 4 4 3 3 3 1 YES YES NO NO NIL 
45 RSB 3 2 3 3 3 2 3 2 2 3 3 2 4 NO NO NO NO NIL 
46 RSB 3 3 4 5 4 4 3 3 2 2 2 0 2 NO YES NO NO NIL 
47 TEA 3 2 3 3 3 2 3 2 2 3 3 3 3 NO NO NO NO NIL 
48 TEA 3 3 4 5 4 4 3 3 2 2 2 0 1 NO YES NO NO NIL 
49 RSB 2 2 2 1 2 3 2 1 1 3 1 2 4 NO NO NO NO NIL 
50 TEA 2 2 2 1 2 3 2 1 1 3 1 2 4 NO NO NO NO NIL 
51 RSB 3 2 2 2 3 2 2 2 2 2 1 1 4 NO NO NO NO NIL 
52 TEA 2 2 2 2 3 2 2 2 2 2 1 0 3 NO NO NO NO NIL 
53 RSB 3 5 3 4 2 3 2 2 2 2 2 1 2 NO YES NO NO NIL 
54 TEA 2 3 2 2 3 2 2 2 2 2 2 1 3 NO NO NO NO NIL 
55 TEA 2 2 2 3 2 3 3 2 2 3 1 1 4 NO NO NO NO NIL 
56 TEA 2 2 3 3 2 2 2 2 2 2 2 3 4 NO NO NO NO NIL 
57 RSB 2 3 2 2 3 2 2 2 2 2 2 2 3 NO NO NO NO NIL 
58 TEA 2 6 8 6 5 5 7 4 4 3 3 2 1 YES YES NO NO NIL 
59 TEA 1 3 4 5 4 4 3 3 2 2 2 1 1 NO YES NO NO NIL 
S.NO Group PS 
VAS 
PONV        
Score 
Patient             
satisfac  -
tion 
TechnicaL      
Failure Rescue          Analgesia 
Brady -
cardia 
Hypo- 
Tension 
Respiratory            
Depression 15 30 2 4 8 16 24 30 36 48 
60 TEA 1 3 2 3 3 2 3 3 2 2 2 0 3 NO NO NO YES NIL 
61 RSB 2 2 2 2 2 2 3 2 1 2 2 2 4 NO NO NO NO NIL 
62 TEA 3 2 2 2 2 2 3 2 1 2 2 1 4 NO NO NO NO NIL 
63 RSB 2 2 2 3 2 3 3 2 2 3 1 1 4 NO NO NO NO NIL 
64 RSB 2 8 8 7 5 5 6 6 5 5 5 1 1 YES YES NO NO NIL 
65 RSB 1 2 2 1 3 2 2 2 1 3 2 2 3 NO NO NO NO NIL 
66 TEA 2 2 2 1 3 2 2 2 1 3 2 0 3 NO NO NO YES NIL 
67 TEA 3 2 2 2 1 2 2 2 2 2 2 3 4 NO NO NO NO NIL 
68 RSB 2 8 8 6 6 5 5 7 7 5 5 1 1 YES YES NO NO NIL 
69 RSB 2 2 1 3 3 3 3 2 2 3 1 1 3 NO NO NO NO NIL 
70 TEA 1 2 2 2 1 2 2 2 2 2 2 0 4 NO NO NO NO NIL 
71 TEA 1 8 5 7 6 5 5 7 6 4 4 2 1 YES YES NO NO NIL 
72 RSB 2 3 3 1 2 3 2 1 1 2 3 1 3 NO NO NO NO NIL 
73 RSB 2 2 1 3 3 3 3 2 2 2 1 0 4 NO NO NO NO NIL 
74 TEA 2 3 3 1 2 3 2 1 1 2 3 0 4 NO NO NO NO NIL 
75 RSB 2 3 1 2 1 2 3 2 2 3 2 0 3 NO NO NO NO NIL 
76 TEA 3 3 1 2 1 2 3 2 2 3 2 2 4 NO NO NO NO NIL 
77 RSB 2 2 3 3 3 2 3 2 2 3 3 0 4 NO NO NO NO NIL 
78 RSB 2 2 3 3 3 2 3 2 2 3 3 0 4 NO NO NO NO NIL 
79 RSB 3 8 7 7 8 8 7 7 6 5 4 0 1 YES YES NO NO NIL 
80 TEA 3 3 3 3 5 5 4 4 2 2 2 0 2 NO YES NO NO NIL 
81 TEA 2 2 2 2 2 3 2 1 1 3 1 2 4 NO NO NO NO NIL 
82 TEA 2 3 3 2 2 3 3 2 2 3 2 0 4 NO NO NO NO NIL 
83 RSB 3 3 2 3 2 2 2 3 3 3 2 0 4 NO NO NO NO NIL 
84 TEA 2 2 3 3 3 3 3 2 2 3 3 2 4 NO NO NO NO NIL 
85 RSB 2 2 3 3 3 3 3 2 2 3 3 0 4 NO NO NO NO NIL 
86 TEA 2 3 2 3 2 2 3 3 2 2 3 2 3 NO NO NO NO NIL 
87 RSB 2 4 3 4 3 3 3 4 2 3 2 2 3 NO YES NO NO NIL 
88 RSB 2 2 3 3 3 3 2 3 3 2 2 1 4 NO NO NO NO NIL 
89 TEA 1 3 3 2 3 2 3 3 2 2 2 0 4 NO NO NO YES NIL 
90 RSB 1 2 2 1 2 3 2 1 1 3 1 1 3 NO NO NO NO NIL 
S.NO Group PS 
VAS 
PONV        
Score 
Patient             
satisfac  -
tion 
TechnicaL      
Failure Rescue          Analgesia 
Brady -
cardia 
Hypo- 
Tension 
Respiratory            
Depression 15 30 2 4 8 16 24 30 36 48 
91 TEA 3 2 3 3 3 2 3 2 2 3 3 2 4 NO NO NO YES NIL 
92 TEA 1 8 8 5 4 4 5 5 4 4 4 0 1 YES YES NO NO NIL 
93 RSB 2 3 3 3 3 3 3 3 2 2 2 1 4 NO NO NO NO NIL 
94 RSB 2 4 3 4 3 3 3 3 3 2 2 1 3 NO YES NO NO NIL 
95 TEA 2 2 3 3 3 2 3 2 2 3 3 0 4 NO NO NO NO NIL 
96 RSB 2 7 7 6 6 5 6 6 5 4 3 0 1 YES YES NO NO NIL 
97 TEA 2 3 4 3 4 3 2 2 3 2 2 0 3 NO YES NO NO NIL 
98 TEA 1 2 3 3 3 3 3 3 2 2 2 3 4 NO NO NO YES NIL 
99 RSB 2 3 3 3 2 3 2 2 3 2 2 2 4 NO NO NO NO NIL 
100 TEA 2 3 3 2 3 3 3 3 2 2 2 2 4 NO NO NO NO NIL 
 
 
 .NO GROUP 
PULSE RATE SYSTOLIC BP 
15 30 2 4 8 16 24 30 36 48 15 30 2 4 8 16 24 30 36 48 
1 RSB 96 98 88 84 90 92 88 88 86 85 124 120 128 124 130 128 120 118 116 124 
2 RSB 86 80 82 88 84 86 82 80 78 77 122 116 112 122 124 120 116 125 122 120 
3 TEA 88 96 94 90 99 86 102 92 86 84 110 116 112 108 124 118 112 110 116 118 
4 TEA 86 86 90 92 84 78 76 80 82 76 114 90 106 120 92 108 102 116 120 124 
5 RSB 78 88 86 90 90 86 84 88 82 88 122 130 128 132 128 132 126 125 127 131 
6 TEA 90 94 90 92 90 84 86 88 90 88 128 132 130 128 125 134 128 126 130 122 
7 RSB 88 86 80 84 88 80 82 78 82 76 125 120 122 128 120 136 132 124 122 120 
8 RSB 104 112 100 96 100 102 92 88 90 88 139 136 132 135 130 136 139 130 132 130 
9 RSB 82 80 76 78 68 66 64 76 74 70 126 96 102 104 122 112 110 112 114 112 
10 TEA 66 78 96 70 88 78 70 68 70 84 118 90 98 100 114 112 122 118 116 115 
11 RSB 78 88 84 85 82 76 78 85 82 76 125 122 120 125 121 130 128 127 130 132 
12 RSB 98 90 88 84 86 78 86 85 84 86 120 114 115 118 128 125 117 110 115 112 
13 TEA 85 80 78 82 78 82 84 84 82 90 112 108 108 132 118 116 110 114 117 109 
14 TEA 95 90 88 92 86 88 85 90 86 88 96 120 118 110 88 108 125 112 120 98 
15 RSB 78 76 74 70 88 84 80 82 80 84 128 122 120 118 114 118 124 122 120 122 
16 TEA 90 87 88 84 86 84 90 88 86 90 135 130 132 127 128 126 128 130 132 128 
17 TEA 86 88 80 78 76 86 80 88 80 83 98 120 106 120 90 116 114 118 114 118 
18 RSB 90 112 104 80 86 100 94 88 92 88 120 118 116 117 125 128 122 120 118 124 
19 RSB 74 78 76 74 76 74 70 68 70 76 118 112 115 114 118 110 113 108 112 104 
20 TEA 78 88 76 78 80 78 80 84 78 68 136 130 138 127 125 130 132 135 132 128 
21 TEA 84 82 86 84 84 82 78 82 80 77 125 120 117 115 113 128 126 125 120 119 
22 RSB 82 74 76 74 84 80 84 82 80 84 135 130 132 128 127 133 125 120 124 122 
23 RSB 88 84 86 82 82 86 88 90 84 88 127 125 120 122 120 132 128 122 120 128 
24 TEA 86 80 84 82 74 80 82 80 82 76 124 120 122 128 117 110 127 125 120 117 
25 TEA 78 80 86 78 78 80 74 76 72 70 122 94 100 112 116 114 118 125 122 126 
26 TEA 60 64 66 62 64 66 62 66 64 74 126 120 118 115 127 122 128 125 126 122 
27 RSB 75 76 74 72 70 72 74 78 75 88 134 130 132 127 125 132 120 128 125 127 
28 TEA 74 70 72 70 72 78 78 75 74 86 120 110 114 118 126 122 117 114 118 115 
29 RSB 96 90 94 92 96 88 86 90 88 84 112 118 116 115 110 118 108 106 114 110 
.NO GROUP 
PULSE RATE SYSTOLIC BP 
15 30 2 4 8 16 24 30 36 48 15 30 2 4 8 16 24 30 36 48 
30 RSB 112 100 92 100 98 102 100 92 88 80 112 114 116 118 114 108 112 110 108 110 
31 TEA 77 75 72 76 84 80 82 84 74 77 117 114 122 117 112 123 117 114 126 120 
32 RSB 92 90 88 88 92 90 82 84 88 85 128 126 120 120 116 118 110 124 118 115 
33 RSB 70 74 78 76 78 72 76 74 78 78 112 110 108 112 116 108 106 114 110 112 
34 TEA 68 64 62 68 68 66 64 62 64 80 98 114 122 126 92 118 106 130 108 120 
35 RSB 98 90 88 86 92 90 88 84 86 84 124 120 122 115 111 108 110 117 108 114 
36 TEA 78 78 72 82 75 70 72 74 76 80 128 122 120 118 124 120 127 118 122 118 
37 TEA 64 62 66 68 68 62 64 68 62 73 127 98 96 112 120 115 117 110 114 116 
38 RSB 106 98 92 94 92 88 86 92 88 80 120 118 114 122 110 116 115 122 114 120 
39 RSB 88 92 90 86 86 88 86 88 86 86 136 132 135 130 133 130 127 125 128 132 
40 TEA 96 90 88 90 86 90 85 80 86 88 138 130 126 129 125 130 127 124 118 122 
41 TEA 114 108 96 98 92 100 90 90 88 76 104 112 108 102 90 114 122 108 109 112 
42 RSB 88 84 82 86 86 84 82 86 84 86 132 130 128 127 124 122 130 132 128 124 
43 RSB 84 80 82 86 82 84 78 74 78 75 136 130 128 132 124 126 128 134 122 128 
44 TEA 92 104 82 98 76 72 98 90 70 77 127 122 126 120 128 117 116 118 114 125 
45 RSB 95 90 88 88 86 92 90 88 86 84 125 118 122 117 125 128 114 120 116 120 
46 RSB 90 88 102 96 90 84 82 88 84 82 120 118 119 120 118 114 116 125 120 115 
47 TEA 72 74 78 70 78 80 82 74 76 74 136 130 128 124 130 125 132 122 130 125 
48 TEA 74 78 88 88 92 98 86 72 88 77 122 118 115 116 122 120 116 120 116 114 
49 RSB 68 66 70 68 62 66 60 64 66 74 130 124 126 122 128 123 132 126 124 122 
50 TEA 88 86 80 78 86 84 88 84 80 75 112 110 108 115 116 110 114 110 112 116 
51 RSB 88 84 88 90 86 85 90 84 86 77 132 128 125 122 120 132 125 127 122 128 
52 TEA 88 80 85 88 80 78 87 80 79 74 122 100 106 122 124 120 116 125 122 120 
53 RSB 102 108 92 74 70 74 70 72 70 78 136 130 132 128 130 125 122 130 127 124 
54 TEA 74 70 78 70 74 68 72 72 70 77 118 112 115 110 116 118 110 112 108 110 
55 TEA 72 76 78 80 84 80 78 76 74 78 128 120 122 120 118 115 122 116 114 110 
56 TEA 80 83 80 79 80 76 79 81 83 88 128 116 118 122 125 134 128 126 130 116 
57 RSB 92 85 80 88 85 83 80 86 80 84 125 116 120 118 120 124 114 118 122 118 
58 TEA 100 118 120 106 98 90 92 80 77 73 128 116 114 118 122 112 110 122 114 117 
59 TEA 78 92 90 94 88 78 82 76 74 75 138 130 128 125 130 128 125 133 128 125 
.NO GROUP 
PULSE RATE SYSTOLIC BP 
15 30 2 4 8 16 24 30 36 48 15 30 2 4 8 16 24 30 36 48 
60 TEA 75 70 72 78 72 74 73 70 72 76 116 90 98 100 114 112 122 118 116 115 
61 RSB 70 74 77 69 72 75 69 71 72 73 134 122 120 122 114 118 116 122 119 121 
62 TEA 70 76 78 80 72 70 74 74 78 77 118 116 115 122 128 120 125 130 120 116 
63 RSB 74 79 80 77 82 80 77 71 73 80 122 114 112 120 118 115 114 118 113 115 
64 RSB 108 100 102 94 98 82 86 92 74 86 128 125 122 130 132 122 126 130 122 125 
65 RSB 68 66 70 74 72 76 74 70 72 88 135 130 127 125 134 128 132 130 128 125 
66 TEA 70 66 67 73 77 75 68 77 74 76 120 94 102 117 116 128 122 100 113 124 
67 TEA 88 82 86 84 84 82 84 80 82 78 126 120 125 118 114 122 120 125 126 118 
68 RSB 114 122 108 100 96 90 88 94 82 74 137 130 127 125 128 132 130 127 133 128 
69 RSB 84 80 82 86 84 82 88 82 80 76 128 120 122 125 132 125 120 128 120 128 
70 TEA 66 69 70 71 76 69 67 70 65 70 132 121 115 114 126 110 117 108 112 125 
71 TEA 112 106 104 98 94 98 86 80 88 85 135 127 132 122 127 126 125 119 124 116 
72 RSB 88 90 92 90 92 90 94 86 88 86 118 114 116 122 126 120 127 115 118 114 
73 RSB 78 74 70 72 70 69 71 78 76 77 127 125 120 122 118 123 129 122 120 116 
74 TEA 80 86 83 81 76 77 79 71 73 72 112 94 100 112 116 114 96 109 122 119 
75 RSB 78 80 84 82 84 82 86 80 76 79 130 125 122 126 128 120 122 128 132 128 
76 TEA 92 97 93 90 86 90 85 91 86 84 126 112 118 115 119 122 128 125 117 121 
77 RSB 88 82 85 82 84 91 87 85 84 80 112 114 116 118 114 108 112 110 108 110 
78 RSB 90 96 94 96 88 96 88 85 86 82 132 130 128 125 124 128 126 130 128 125 
79 RSB 88 102 100 98 96 99 86 84 89 78 127 122 126 130 128 128 123 120 118 116 
80 TEA 88 90 94 98 90 92 90 96 88 74 125 120 128 127 125 124 120 122 130 122 
81 TEA 83 77 74 79 84 86 78 74 77 75 136 122 122 117 121 123 117 119 126 117 
82 TEA 88 82 85 90 82 77 81 77 79 74 112 110 108 112 116 108 106 114 110 112 
83 RSB 77 70 79 81 80 78 74 79 73 77 132 124 122 135 130 128 124 130 132 125 
84 TEA 92 90 88 86 92 87 85 86 88 75 136 130 128 120 130 127 128 130 125 120 
85 RSB 86 80 74 78 82 85 84 80 78 73 108 110 112 110 115 112 108 112 110 107 
86 TEA 80 77 79 82 79 77 74 80 77 74 128 90 98 118 124 96 127 92 122 118 
87 RSB 98 79 86 84 80 77 79 88 74 86 104 122 108 112 120 115 117 110 114 116 
88 RSB 87 84 90 84 79 91 83 84 86 84 132 130 128 127 124 122 130 132 128 124 
89 TEA 88 86 80 84 84 86 90 82 85 77 126 122 120 126 127 118 114 125 120 122 
.NO GROUP 
PULSE RATE SYSTOLIC BP 
15 30 2 4 8 16 24 30 36 48 15 30 2 4 8 16 24 30 36 48 
90 RSB 84 86 84 88 84 88 82 85 86 86 118 112 116 114 120 118 126 122 120 116 
91 TEA 86 80 92 90 88 82 86 88 80 76 108 106 122 120 98 112 108 116 122 106 
92 TEA 108 100 98 88 86 84 100 92 82 79 120 117 115 122 116 112 118 122 113 118 
93 RSB 90 88 84 88 89 93 87 84 88 84 136 130 128 132 124 126 128 134 122 128 
94 RSB 92 90 98 82 84 74 78 72 70 74 127 122 126 120 128 117 116 118 114 125 
95 TEA 66 68 78 70 74 72 70 66 68 74 117 111 115 120 115 116 112 114 116 112 
96 RSB 100 104 98 88 92 86 94 98 82 76 138 134 132 130 132 128 136 130 128 125 
97 TEA 88 96 94 84 75 85 74 73 76 86 136 130 128 124 130 125 132 122 130 125 
98 TEA 85 87 89 82 91 78 83 85 80 83 122 92 98 116 122 120 116 120 116 114 
99 RSB 78 76 80 72 75 80 84 80 82 88 130 126 118 114 127 120 122 125 126 120 
100 TEA 90 87 85 80 86 85 87 84 83 78 130 96 106 122 128 121 132 125 117 119 
 
 S.NO GROUP DIASTOLIC BP MAP SpO2 
    15 30 2 4 8 16 24 30 36 48 15 30 2 4 8 16 24 30 36 48 15 30 2 4 8 16 24 30 36 48 
1 RSB 76 80 72 75 73 82 70 73 81 74 92 93 91 91 92 97 87 88 93 91 99 100 100 99 98 99 99 99 98 100 
2 RSB 77 71 73 75 70 69 71 76 71 70 92 86 86 91 88 86 86 92 88 87 100 100 99 99 100 98 99 98 100 99 
3 TEA 85 82 78 73 70 82 77 79 80 81 93 93 89 85 88 94 89 89 92 93 99 98 100 98 99 99 99 99 100 99 
4 TEA 77 68 70 72 66 64 68 67 72 73 89 75 82 88 75 79 79 83 88 90 100 100 99 99 99 98 99 100 100 100 
5 RSB 66 68 70 71 65 73 64 63 67 63 85 89 89 91 86 93 85 84 87 86 100 99 99 99 99 98 100 100 100 100 
6 TEA 85 81 80 78 77 74 72 75 77 73 99 98 97 95 93 94 91 92 95 89 99 99 100 99 98 99 99 100 100 100 
7 RSB 74 70 72 69 67 70 66 69 71 68 91 87 89 89 85 92 88 87 88 85 99 99 99 99 99 99 99 99 99 98 
8 RSB 74 79 72 68 75 70 77 80 73 69 96 98 92 90 93 92 98 97 93 89 99 98 99 99 97 99 99 99 100 99 
9 RSB 82 66 64 70 68 66 74 72 70 68 97 76 77 81 86 81 86 85 85 83 99 99 99 99 99 99 99 99 99 99 
10 TEA 75 60 66 68 64 70 71 66 69 70 89 70 77 79 81 84 88 83 85 85 98 98 99 99 99 99 99 99 99 99 
11 RSB 79 72 73 81 77 72 82 72 82 74 94 89 89 96 92 91 97 90 98 93 100 100 100 100 100 100 99 100 99 99 
12 RSB 68 65 62 60 73 64 67 71 66 68 85 81 80 79 91 84 84 84 82 83 99 99 99 99 99 99 99 98 99 99 
13 TEA 73 69 77 73 80 81 72 73 75 69 86 82 87 93 93 93 85 87 89 82 100 99 98 99 99 99 99 99 99 99 
14 TEA 68 77 72 72 68 70 78 71 74 70 77 91 87 85 75 83 94 85 89 79 99 99 99 99 97 99 99 99 99 99 
15 RSB 68 67 69 66 70 72 68 67 70 64 88 85 86 83 85 87 87 85 87 83 99 99 99 99 99 99 99 100 99 99 
16 TEA 82 81 78 73 72 75 73 78 72 80 100 97 96 91 91 92 91 95 92 96 99 99 99 99 99 99 98 99 99 99 
17 TEA 70 78 68 72 70 67 71 69 72 70 79 92 81 88 77 83 85 85 86 86 99 99 99 99 99 99 99 99 99 99 
18 RSB 85 80 77 75 73 77 73 78 74 72 97 93 90 89 90 94 89 92 89 89 100 99 99 99 99 99 98 99 99 99 
19 RSB 75 61 63 68 70 69 68 65 71 69 89 78 80 83 86 83 83 79 85 81 99 99 99 99 99 99 99 99 99 99 
20 TEA 79 72 77 68 74 70 82 73 72 67 98 91 97 88 91 90 99 94 92 87 98 99 99 99 99 97 99 99 99 99 
21 TEA 64 68 60 72 70 67 69 74 77 69 84 85 79 86 84 87 88 91 91 86 99 99 99 99 99 99 99 99 99 99 
22 RSB 80 73 72 70 70 75 76 73 74 72 98 92 92 89 89 94 92 89 91 89 98 99 99 99 99 99 98 100 98 99 
23 RSB 78 71 73 69 70 71 68 75 77 73 94 89 89 87 87 91 88 91 91 91 99 99 99 99 99 99 99 99 99 99 
24 TEA 81 78 74 77 72 69 72 65 67 69 95 92 90 94 87 83 90 85 85 85 99 99 99 99 99 99 98 98 98 99 
25 TEA 84 68 70 72 69 68 70 73 68 70 97 77 80 85 85 83 86 90 86 89 99 99 99 99 99 99 99 99 99 98 
26 TEA 71 65 64 70 66 68 70 67 70 66 89 83 82 85 86 86 89 86 89 85 98 99 99 99 100 100 99 99 99 99 
27 RSB 78 80 72 73 75 70 69 77 67 69 97 97 92 91 92 91 86 94 86 88 100 99 99 99 99 99 99 99 99 99 
28 TEA 73 78 70 69 80 74 76 71 67 71 89 89 85 85 95 90 90 85 84 86 99 99 99 99 99 99 99 99 99 99 
S.NO GROUP DIASTOLIC BP MAP SpO2 
    15 30 2 4 8 16 24 30 36 48 15 30 2 4 8 16 24 30 36 48 15 30 2 4 8 16 24 30 36 48 
29 RSB 78 80 78 73 77 81 72 76 72 68 89 93 91 87 88 93 84 86 86 82 99 99 99 99 98 98 99 99 99 99 
30 RSB 72 67 66 69 65 66 70 68 67 70 85 83 83 85 81 80 84 82 81 83 99 99 99 99 99 99 99 99 99 99 
31 TEA 77 70 69 72 67 70 72 70 73 70 90 85 87 87 82 88 87 85 91 87 99 99 99 99 99 99 99 99 99 99 
32 RSB 70 73 77 72 78 73 70 68 81 77 89 91 91 88 91 88 83 87 93 90 99 98 99 99 99 99 99 98 99 98 
33 RSB 79 72 70 74 70 72 70 73 72 75 90 85 83 87 85 84 82 87 85 87 99 99 99 99 99 99 99 99 99 100 
34 TEA 68 70 74 72 70 71 68 70 70 72 78 85 90 90 77 87 81 90 83 88 98 99 99 99 99 99 99 98 99 99 
35 RSB 71 72 69 77 74 69 80 77 73 76 89 88 87 90 86 82 90 90 85 89 99 99 99 99 99 99 99 99 99 99 
36 TEA 76 70 69 71 72 70 68 67 69 70 93 87 86 87 89 87 88 84 87 86 99 98 99 99 99 100 100 99 100 99 
37 TEA 82 63 60 68 71 69 72 70 73 70 97 75 72 83 87 84 87 83 87 85 99 100 99 99 99 99 99 99 99 99 
38 RSB 65 71 74 68 71 74 72 69 78 68 83 87 87 86 84 88 86 87 90 85 99 99 99 99 99 99 99 99 99 99 
39 RSB 67 71 74 69 77 71 80 73 69 73 90 91 94 89 96 91 96 90 89 93 100 99 99 99 99 98 98 99 98 98 
40 TEA 75 71 85 80 75 85 85 85 80 85 96 91 99 96 92 100 99 98 93 97 99 99 99 99 99 99 99 99 99 99 
41 TEA 70 72 77 78 68 73 72 77 70 74 81 85 87 86 75 87 89 87 83 87 99 99 99 99 99 99 99 99 99 99 
42 RSB 79 70 72 77 72 69 73 75 72 72 97 90 91 94 89 87 92 94 91 89 98 99 99 99 99 99 99 99 99 99 
43 RSB 73 69 68 66 70 71 66 69 70 66 94 89 88 88 88 89 87 91 87 87 99 99 99 99 98 98 99 99 99 99 
44 TEA 77 70 73 74 70 72 73 70 71 72 94 87 91 89 89 87 87 86 85 90 99 99 99 99 99 99 99 99 99 99 
45 RSB 82 80 73 80 72 77 69 73 76 70 96 93 89 92 90 94 84 89 89 87 99 99 99 99 99 99 99 99 99 99 
46 RSB 66 69 71 64 69 67 63 65 69 68 84 85 87 83 85 83 81 85 86 84 99 98 99 99 99 99 99 98 100 99 
47 TEA 82 80 76 73 75 71 70 77 75 72 100 97 93 90 93 89 91 92 93 90 99 99 99 99 99 99 99 99 99 99 
48 TEA 73 69 67 70 66 69 67 70 71 73 89 85 83 85 85 86 83 87 86 87 99 99 99 99 99 99 99 98 99 99 
49 RSB 78 77 72 70 73 74 72 70 74 73 95 93 90 87 91 90 92 89 91 89 100 99 99 99 99 99 99 99 98 99 
50 TEA 62 65 69 62 71 69 63 70 68 71 79 80 82 80 86 83 80 83 83 86 99 98 99 99 99 100 100 99 99 99 
51 RSB 70 80 72 80 68 66 72 68 66 72 91 96 90 94 85 88 90 88 85 91 99 100 99 99 99 99 99 99 99 99 
52 TEA 75 60 62 70 67 65 69 70 65 68 91 73 77 87 86 83 85 88 84 85 98 99 99 99 99 99 99 99 98 99 
53 RSB 85 90 85 78 80 88 82 80 88 85 102 103 101 95 97 100 95 97 101 98 99 99 99 99 99 98 98 99 99 99 
54 TEA 66 62 60 68 64 65 72 70 65 73 83 79 78 82 81 83 85 84 79 85 99 99 99 98 99 99 99 99 99 99 
55 TEA 68 64 72 63 70 72 68 62 68 70 88 83 89 82 86 86 86 80 83 83 99 99 99 99 99 99 99 99 99 99 
56 TEA 82 77 74 79 80 73 76 72 77 72 97 90 89 93 95 93 93 90 95 87 99 99 99 99 99 99 99 99 99 99 
57 RSB 78 80 82 77 75 74 76 79 72 74 94 92 95 91 90 91 89 92 89 89 99 100 100 100 100 100 99 100 99 99 
S.NO GROUP DIASTOLIC BP MAP SpO2 
    15 30 2 4 8 16 24 30 36 48 15 30 2 4 8 16 24 30 36 48 15 30 2 4 8 16 24 30 36 48 
58 TEA 73 70 68 70 67 72 69 66 70 69 91 85 83 86 85 85 83 85 85 85 98 99 99 99 99 99 99 98 99 99 
59 TEA 75 80 85 70 68 72 66 70 68 72 96 97 99 88 89 91 86 91 88 90 99 99 98 99 99 99 99 99 99 99 
60 TEA 81 62 64 70 69 72 70 72 73 74 93 71 75 80 84 85 87 87 87 88 97 99 99 99 97 99 99 99 99 99 
61 RSB 83 74 77 73 76 73 78 74 72 77 100 90 91 89 89 88 91 90 88 92 99 99 99 99 99 99 99 100 99 99 
62 TEA 85 90 85 85 80 88 80 80 80 85 96 99 95 97 96 99 95 97 93 95 99 99 99 99 99 99 98 99 99 99 
63 RSB 77 80 85 80 75 85 85 85 80 85 92 91 94 93 89 95 95 96 91 95 99 99 99 99 99 99 99 99 99 99 
64 RSB 68 66 70 72 75 68 70 73 70 72 88 86 87 91 94 86 89 92 87 90 99 99 99 99 99 99 98 99 99 99 
65 RSB 85 90 85 92 80 88 84 80 82 85 102 103 99 103 98 101 100 97 97 98 99 99 99 99 99 99 99 99 99 99 
66 TEA 82 66 69 71 73 77 80 75 73 76 95 75 80 86 87 94 94 83 86 92 99 99 99 99 99 97 99 99 99 99 
67 TEA 70 80 88 80 75 85 82 78 80 77 89 93 100 93 88 97 95 94 95 91 99 99 99 99 99 99 99 99 99 99 
68 RSB 86 90 85 85 95 88 80 80 80 85 103 103 99 98 106 103 97 96 98 99 99 99 99 99 99 99 98 100 98 99 
69 RSB 64 68 62 70 72 70 72 66 64 70 85 85 82 88 92 88 88 87 83 89 99 99 99 99 99 99 99 99 99 99 
70 TEA 75 72 69 67 65 69 70 68 72 71 94 88 84 83 85 83 86 81 85 89 99 99 99 99 99 99 98 98 98 99 
71 TEA 73 67 69 66 70 68 64 67 69 67 94 87 90 85 89 87 84 84 87 83 99 99 99 99 99 99 99 99 99 99 
72 RSB 75 80 85 88 75 83 79 77 83 85 89 91 95 99 92 95 95 90 95 95 100 99 99 99 100 100 99 99 99 99 
73 RSB 81 74 76 70 72 77 72 74 70 71 96 91 91 87 87 92 91 90 87 86 99 99 99 99 99 99 99 99 99 99 
74 TEA 77 60 63 69 75 68 70 69 71 69 89 71 75 83 89 83 79 82 88 86 99 99 99 99 99 99 99 99 99 99 
75 RSB 86 87 85 84 87 88 80 82 82 86 101 100 97 98 101 99 94 97 99 100 98 99 99 99 98 98 99 99 99 99 
76 TEA 72 67 65 68 63 66 69 67 68 69 90 82 83 84 82 85 89 86 84 86 99 99 99 99 99 99 99 99 99 99 
77 RSB 74 70 69 67 69 65 68 70 67 66 87 85 85 84 84 79 83 83 81 81 99 99 99 99 99 99 99 99 99 99 
78 RSB 72 72 77 73 75 72 68 67 75 70 92 91 94 90 91 91 87 88 93 88 99 98 99 99 99 99 99 98 99 99 
79 RSB 85 78 85 77 80 82 80 72 74 79 99 93 99 95 96 97 94 88 89 91 100 100 100 99 100 100 99 100 99 99 
80 TEA 83 80 77 70 71 75 79 82 78 85 97 93 94 89 89 91 93 95 95 97 98 99 99 99 99 99 99 98 99 99 
81 TEA 79 74 73 75 77 72 75 70 73 71 98 90 89 89 92 89 89 86 91 86 99 99 98 99 99 99 99 99 99 99 
82 TEA 71 68 69 72 75 70 73 69 67 68 85 82 82 85 89 83 84 84 81 83 99 99 99 99 97 99 99 99 99 99 
83 RSB 84 80 78 75 77 73 76 74 77 73 100 95 93 95 95 91 92 93 95 90 99 99 99 99 99 99 99 100 99 99 
84 TEA 82 77 80 82 80 78 67 71 77 81 100 95 96 95 97 94 87 91 93 94 99 99 99 99 99 99 98 99 99 99 
85 RSB 68 60 66 62 64 69 72 68 70 66 81 77 81 78 81 83 84 83 83 80 99 99 99 99 99 99 99 99 99 99 
86 TEA 85 65 69 71 73 76 64 78 80 73 99 73 79 87 90 83 85 83 94 88 99 99 99 99 99 99 98 99 99 99 
S.NO GROUP DIASTOLIC BP MAP SpO2 
    15 30 2 4 8 16 24 30 36 48 15 30 2 4 8 16 24 30 36 48 15 30 2 4 8 16 24 30 36 48 
87 RSB 75 69 72 69 70 72 70 73 69 72 85 87 84 83 87 86 86 85 84 87 99 99 99 99 99 99 99 99 99 99 
88 RSB 70 67 66 69 65 71 74 70 67 69 91 88 87 88 85 88 93 91 87 87 99 99 99 99 99 97 99 99 99 99 
89 TEA 75 72 72 78 68 70 71 66 68 72 92 89 88 94 88 86 85 86 85 89 99 99 99 99 99 99 99 99 99 99 
90 RSB 78 90 82 78 80 75 72 74 76 66 91 97 93 90 93 89 90 90 91 83 99 99 99 99 99 99 98 100 98 99 
91 TEA 75 82 85 77 79 82 76 73 80 77 86 90 97 91 85 92 87 87 94 87 99 99 99 99 99 99 99 99 99 99 
92 TEA 82 84 85 77 73 72 76 80 78 85 95 95 95 92 87 85 90 94 90 96 99 99 99 99 99 99 98 98 98 99 
93 RSB 77 72 69 73 75 73 68 68 70 72 97 91 89 93 91 91 88 90 87 91 99 99 99 99 99 99 99 99 99 99 
94 RSB 81 74 74 71 77 73 76 73 70 73 96 90 91 87 94 88 89 88 85 90 99 99 99 99 100 100 99 99 99 99 
95 TEA 71 80 74 77 81 74 82 78 80 72 86 90 88 91 92 88 92 90 92 85 99 99 99 99 99 99 99 99 99 99 
96 RSB 68 60 62 67 59 66 62 66 60 62 91 85 85 88 83 87 87 87 83 83 99 99 99 99 99 99 99 99 99 99 
97 TEA 73 70 69 67 68 70 66 67 66 69 94 90 89 86 89 88 88 85 87 88 99 99 99 99 98 98 99 99 99 99 
98 TEA 81 63 66 72 76 70 73 69 73 74 95 73 77 87 91 87 87 86 87 87 99 99 99 99 99 99 99 99 99 99 
99 RSB 62 58 62 62 66 65 68 71 66 67 85 81 81 79 86 83 86 89 86 85 99 99 99 99 99 99 99 99 99 99 
100 TEA 79 62 64 69 70 72 68 69 72 75 96 73 78 87 89 88 89 88 87 90 99 98 99 99 99 99 99 98 99 99 
 
 
